..

. .

2005

 617-089.81.5
54.5
65

, .
/ .. -.:
, 2005., 350 . - ISBN 5-900-518-35-3.
CIP

,
, .
,
.

.

.
,
,
. .. .
:
1. , ,
, ,
.
2. ,
.
, , .

ISBN 900518-35-3

..
2005

...............................................................................................

1.
............................................................. 10
...................................... 13
................................................. 15
........... 16
1................................................................................ 19
2.
............................................................................ 21
.............................................. 22
.............................................................................. 24
. . . . 25
................................................... *27
................................ 27
............................ 28
.............................. 28
............. 30
,
............................................................................................. 31


- ........................................................... 33
..................... ................................. 33
.......... 34



........................................................... 36

. . . 39

()
.......................................... ! ....................................... 41


................................................................ 42
, .................................... 42


. . . . 45

......... 47

................................................................................................. ..47

................................................................. ..48

................................................................. ..49
---- -51

3.
. *............................................................. 53
.......................................................................... 55
.......................................................................... 56
...................................................................................... 61
............................................................................................... 63
....................................................................................... 63
........................................................... 66
............................................................................................. 73
........................................................... 73'
....................................................... 77
.......................................................................... 78
.................................... 78


................................................................... 82
........ 85
................................................................... 86
............................................................................ 87
3 ................. ........................................................... 88

4.
................................................ 91
......................... 91
.......................................................................... 91
................. 91
.................................................................. 91
........................................................ 91
.............................................................................. 92
............................................................... 98
................................................... 99

........................................................... 102

........................................................... 102
,
..............................................

4 .........................................................
*.........4

 5.
- ........................................................... 108
................................................................... 108
............................................................. 109
......................................................................... 116
.................................116
___116
....................................................... 117
.................................121
...............................................121
................................................................................. 121
............................................................. 122
. : .........................................122

.......................................................................................... 123
/ .. .\ 124
/
........................................................... 126
............................................................. 131
............................................................... 132
............................................................... 134
................................................................. 135
5 ........................................................................... 136

6.
6.1.
.....................................139

.........................140

........................................................... 143
...................................145
............................................................. 151
6 .1 ..................................................................... 152
6.2.
.................... .............................................. 155
155
.....................156
............ 157

.............................169
6 .2 ............ ........................................................ 172
6.3. . . . 174
.....................174
...............................178

 6.3 . . . ...............................................................179
6.4.
........................ .............................. 181
.......................................185
6.4 ..................................................................... 187
6.$. ...................................189
.....................................................189
........................................................................................... 190
............ ..........191
.............................................192
...............................................................193
6 .5 .............. ...................................................... 194
6.6. ...................................195
.......... v..........................195
.................... 196
.......................................197
...........................................197
6 .6 ..................................................................... 198
6.7. ...................... 199
.. .*................ .............................................. 199
- .....................................................201,
................................................................. 201
................................................................. 203
........................ ................................ 204
........................................................... 206
............................................................................. 207
.....................................................208

-.. .209
............................ ................209
............................................................................... 211
6.7 ................................................................... 212
6.8. .............................. 214
................................................................. 217
................ .......................................................... 235
6.8..................................................................... 236
6.9.
.............................. : ..................................239
............ 240
.................................242
.............................................244
.
........................ 250

.................. 256
6.9 ....................................................................... 260

 7.
..........261

..................................................... 266
........................................................... 266
....................... 268
.................................................................................. 282
............................285
...............................................292
................. 298
7 .............................................................................. 303
8.

.....................................................................................309
. . . , .....................................................................................313
, ........................................ 313
............................................................................................... 314
8 .............................................. ............................... 325

9.
..................................................................327
.......................................................................... 330
............................................................................................. 331
................. 336

......................................................................................... 342
............................................................................ : ____344
............................................................. <. . . . 344
............................................................ .........................344
....................................................................346
...................................................................................346
.......................................... .................................................. 347
............................................................................................. 348
............................349
9 .............................................................................. 350



,
, ,
, . ,
,
,
.
, ..
, ,
( )
.

,

, ..
.
,
.
, , :
,
,


.
,
,
.

, . . .
.
:
1. , ,
, ,
.
2. ,
.
,
, , ,
. , , ,
, ,
, ,
, ..,
, . ,

 , , -

,
, .
>

, ,
, . ,
, ,
.
,
,
. ,
,

.
,
,
, .
, , ,
.
. . ,
,

. .. \



..

,
.
,
, ,
,
() .
, ,
- ( ,
, .),
, ,
..

( .., 1988),
:
( );
;
;
,
( . anaisthesia), ,
, ,
. ,
,

. ,
,
,
. -
, ,

II 1 1

.
,

.

, . (
.. ., 1998)

, , -,
. ;
( )
, ;
() ,
. :
;
- (
, : ,
);

.
, , -,

. , (
.., 1992; .., 1994):
,

(, , ), ,
.

^
Guedel (1949).

, , (
) . (
)
. ,
, "
.
.
:
() ,
;
( ), -

 ,
; , , : ,
, ,
;
;
;
v

,
, ,
,
.
: -1
, .

:
, , ..
.
,
, ,
,
:
, , .
.

, ,
,
.
( . narkosis )
.
,
,
, ,
.
.
,
. ,
2-3 III Guedel,
.
,
. ,
( ), .
.
;

. .
, , .

,
,
, , ,
, ( .., ..,
.., 1994).

- ( .., 1988).

. ,
, ,
.

:
, ..
;
, ..
;
(),
;
, ,
( !) ( , ).
,
,
.

.

^^
,
:
(
, ,
,
(
, );


(, , ..);

();
( ~
3).

13


:
, ;

.
,
(
, ..),

. ,
( .., 1994).
( .. ., 2000):

;
, ;
.
,
,
.
,
, , ,
, , ,
(,
, .).
, ..

.
, ,
, .

, /
, .

.

,
, -
.
.

,
, - , ( .., 1998).
-
,

. ,

,
.
, ,
,
, ..
.

.


, ,
..

:
;
;
;

( , , );
^ (
, ).
, .
,

,
.

. ,


.
.

,
.
, - ,
.
,
,

15

1 6 1

,
.
.

,

. ,
,
, .
,, ,
,

.


.
, .



(Birch R , Anson , Gelister J, et al. 1990;
.., 1997; .., .., 1998; .,
. .., .., ., 2000).
, ..

.

, , ,
,
( ., 1995).
.
,
,
(
, ,
) (Birch R , Anson , Miller et al., 1989, 1990;
.., 1996; .3.,1997), ,

( .., 1997).
, ,
, .

,
.

,
,
( ).

.
(Whitwam J.G., McCloy R.F., 1998; Engberg et af., 2000)
( . ., 1998; .., .., 1998;
.. ., 1999) ,
.
,
, , ,
,
, ,
,
(Whitwam J.G.,
McCloy R.F., 1998).
, ,
, . .
, ,
,


(Whitwam J.G., McCloy R.F., 1998). ,
,
. ,
, ,
.
1990 .(.Birch,
K.Anson, R.Miller), ,



. 1020
,
.
,
(B.Birch, K.Anson, R.Miller et al., 1990, 1991, 1997; Kenny
G.N., 1996; Graber RG., 1999).
, , ,

(),
, .

17

 , ,

( ., ., 1999).
(Whitwam J.G., McCloy R.F., 1998):
1. .
2. .
3. .
4. .
5.
().
6. (
) .
,
:
(

);
;

;

, ;
-
; .
,
;
.
, ,
, .

, ,
. ,
.
,
,
,

.


, ,
, . , ,
, .

1. .. ,
, .
, 1998.
2. ..

. ...., . .
, . , 1994 .
3. ..
. . . .
. . , 1992 .
4. .., . .., ..,
..
..
1999.1- . . 2000 . . .32-33
..,. . , 1998 .
5. ..,. . ,
1998 .
6. ..
()
, , .
, 1998.
7. ., ..
,
, .
, 1998.
8. .. . ,
1995 ., . 131-146.
9. ..
/ / - . , 1996.
10. ..
. .
. . .. 1997.
11. .., .., .., ..

. . . . ( ). ., 1995, . 6-8.
12. -., .. . 2-
. , 1998 ., 1- .
13. Engbers , Groen-Mulder S., Vuyk J. On the Stady and Practice of
Intravenouse Anaesthesia, Kluwer Academic Publishers, 2000.
14. Whitwam JG & McCloy RE Principles and Practice of Sedation. 2nd

19

Ed. Blackwell Science. 1998.

15. Kenny G.N. Patient sedation: Technical problems and develop
ments, European Jomel of Anaesthesiology, (Suppl.) 1996: 13, p. 18-21.
16. Birch R P, Anson KM , Gelister Jand Miller R A. Sedoanalgesia in
Urology: Technique Applications and Impact World J Urol, 1989; 7:
17. Miller R A, Gelister J, Lei C, Parker C, Anson M, Grant D and
Birch R P. Advances in Minimally Invasive Surgery of the Prostate. World
J Urol, 1989; 7: 158-161.
18. Chappie R, Gelister J S and Miller R A. Minimally Invasive
Surgery for the Retrieval of Complex Fractured Double J Stents. Br J Surg
1989; 76: 680.
19. Miller R A, Birch BRP, Anson M, Bell J, Gelister J and Grant D.
The Impact of Minimally Invasive Surgery and Sedoanalgesia on Urological
Practice. Royal Postgrad Med J, 1990; 66: (suppl) 572-576.
20. Birch B R P , Anson M, Gelister J, Pardu and Miller R A. The
Role of Midazolam and Flumazenil in Urology Acta Anaes Scand, 1990; 34:
25-32.
21. Birch BRP, Anson M, Gelister J and Miller R A. Sedoanalgesia
A Safe, Cost Effective Alternative to General Anaesthesia. A Review of
1,020 Cases.Br J Urol 1990; 66: 342-350
22. Birch B, Anson K, Kalmanovich D, Cooper J, Miller R.A.Sedation
for day case urology: An assessment of patient Recovery Profiles following
Midazolam and Flumazenil. Annals of College of Surgeons 1991; 73: 373378.
23. Murphy P.G., Myers D.S., Davies P.J. et al. The Antioxidant
Potencial of Propofol. British Journal of Anaest. 1992; 68: 613-18.
24. Graber RG. Propofol in the endoscopy suite: an anesthesiologist's
perspective [editorial]. Gastrointest Endosc 1999;49:803-6. .


..

, ,
.
,
,
,
.


. ,
, ,
. ,
,

, , . ,

, .
:
/ ,
.
, ..

, ,
.

,

.


.

22 I

.


:

.

.
,
.
,
,
.
, , , ,
. -,
, :
, .
, .

.
:
,
, ,
.
.

, .
.
- - .
.
.
- ,
, , , , ,
,
-

, () .
. ,

. , ,
,
,
.

.
.
,
, .

,
. , ,
. ,
, ,
,
.. , .. ,
,
,
.
.

. ,
,
.
,
: ,
()
. ,
,


.
,
-
: , ..
' ,
, ,
.
. ,

- .
:
? , ?.

.

: ,
, - .
,

23

24 I

.
, ,
, , , .
. , ,
, ,
.
, ,
.
. ,
, ,
.
, ,
.
,
.
, , ,
(,
..). ,
.
.
,
. , ,

. .
, , ,
. ,
,
.
n. , ,
.
,
, .
.
,
( ).

.

,

.
- , ,

, .
,
.
, , .
.

, .
(
).
.

.
, (
), .
,
,
.
,
,
.
.
, .

- ,
.
,
, ,
.
,
.
RW,
, .

,
: ,
, ..
:
, .
3
.
.

25

26

. , 20
25% ,
, .

.
.
. ,

.
.

.
, 1
, .


- .
, ..
-

.


.
,

.
25%
, 50%

, ,
,


..

40 , , ,
.
.

.
,
,
.

I27

.


( ,
).
, -
.

,
. ,

, ,
.
,
.
.

.

.
, (
) ,
de facto
.

.

; ,
,
,
.
,
:
,
.

28 I

.
.

,
;
, ..

.
.

, ,

, .
,
, ;

, .

, ,
,
()
. ,
, . , ,
,
:
1.

. ,
: ,
, , ,
., , ,
( , ,

).
t
2. ,
, , , .. ,

?.
3. ,

,
: ()
, , ,
,
,
, (, )
; ,

, (
.., 2002)
:
, ;
,
;
;
;
:
, ,
;
( ) (
,
) .
,
,
.
:
,
,
.
, ,
.

(, ).
, .

,
, ,
; ,
; ,
...
,
.

. ,

29

al

.
( ,
* , --
),
.
, , ,
.
,
. .
, ( ?) ()
. -.
, , ->
. ,,

.

.

:
,
;
;
:
, ;

,
, ,
;
,

;
.
,
. ,
,

.
^
.

,

, :
1 200000 (Boij, 2001).
,
,

.
:
,
.
, .
,
, ()
, .
:
,
,
,
, ()
- , ,
..

,
.

. ,
,
.

(American Society of Anaesthesiologists
(ASA):
1 ^, .
2
,
.
3 ,
() ,
, .
4 ,
.

31

32 II 2
5 , 24
,
.
. ,
().
40- XX
.

.
, ,
,
.
- '
.
:
1. (.. , 1984)
,
,
. ,
,

() .. ,
, ,
, -
..
2.
,
. ,
,
, ,
.
, ASA

,
. ,
ASA2
,
ASA4. , ASA2
, ASA4 .
,
ASA


.

______________________________________________________ || 33

-
-

, .
,
1 . ,
.
,
.
()
(), ,
.

^_^^|

,
.

(02) (MV02).
, ,

.
, ,
.
:
-;
;
.
,
.

. , -, ,
,
.
.

, , ,
. 3

 (
,
).
, ,
,
.

,
. (,
),
( ,
).
.

:
12 ;

;
;

, ST, ;
,
,
( , ),
;

,
;

.
, :
,
. , ,
,
.
,
, ,
.

. ^
,
.

:

-
.
( ..).
()
2 /(*2) 40%:
().
.
-,
.

.
.
, .. ,
,
. 30% ()
.
50%
.
. ,
.
, .
, ,
4 6 ;
.
. ,
,

;
. , ,
.
. . 9.

35






( ) - . ,

,
.

. ,


.

,
- , , ..
.

()
().
,
.
.
:
, :
,
(
).
, . ,
, ,

.
.
- ().


. -
. -
, ,
, , ..
. -

37

,
. , ,
- ,

. -
,
. 60 70%.
,
.

,
(. . ).
,
.
:
;
;
;
(
, -; ..);
.

.
- .
, .
.
, .
() ,
.

.
(
), ,
, . - .
.
2-3
. , ,

, .
:
( ). ,
;

;
,

, , ..
,
- .
,
.
,

,
. ,
, ,
,
.


.
, .
,
,

() . ,
(,
,
), Na (
),
.


.
.
.

.
,
.
(
) , ,
.
().
.
,
,
.
.
.
.

-
. ,

.
, ,
.
,

.

(,
)
.
:
. 02
60 Hg
-
.
02 45 Hg

.
.
. (
) , ..
.
:
, .;

, ..
pH, 02,
.


. ,
,
.
,
. - :
, (
2.5 ), ,
.

39

 .

, ,
-
.
( 24-48 )
.
. 2 4

.

. , ,
. - >
.
. (, )
,
.
, ,
,
, ,
.

()
,
:
(
;
}- 2-
(, , ..)
;
;
; 2-
(), , );
()
(*
( , ,
; -/
300 1500 /;
7 ;

41

,
- ;

,
;
;
() ( );
, ;
;
, .

, -
, .
-
.
.

- . ,
.

.
., ..
.
()
, -
.

- .

. , - *
,
(Qs/Qt).
, ,

. , ,

.
.

. -

 - ,
(
,
).
27%,

47% .

- ,
.

.
\

,


,

.
.
,
.

(),
- . ,
, -:
.
, ,
.
. , - -
. ,
- *^
. , 50 /
. () $

. ,
.
. 2%
-,
. ,
-
15 /,
.
, , -
- , , .

.

.
*
,
, .

:
;
, ,
, ,
;

;
;
;
;
, 50%
(
).
1
, .

43

 II 2

,
. 90 - 95% .
, ..
,
.
. ,
-,
, ,

,

()

,
,
.
- .

, .

(,
,
)

. Na

()

,
, .
,
, .
, , *

, '

.

. ,
,
, ..
.
,
:
, , ;
(,
, +,
, ).
() ,
, , ..
pH, , .
.
. 1020, ,
cfpaae. ,

. , .
,
(. 5-1).
(BUN)
. ,
, ;
. 6 12 /.
, , 2 50%
;
(). 80 - 120
/. ,
. :
= 40 - ) ()
72 [ ]
0.85 ;


.
, Na+ 131 / 150
/, +, , 2.5 / 5.9 /.

45

 .
.

:
, ..
;
;
> 50 /
;
50 20 /

; .
*
< 20/, ,
;
,
;
,
, ;
;
(, , );
.


.
.
,
.
.
,
(
).
. ,
-
().
, ,
.
. ,

.
-?
.
0.5 1 /(*). \\
- 25 /. ^
:

;
;

( 2 4 /(*);
-12.5 25 /;
20 40 /.
.
,
.

, * ,
. ,
.

,
,
.

.

, , , ,
ECHO, ,
(, , , ,
) .
- (ACT), (), ()
.
. - .
2- .
VI .
,
, 100% .
.
(). , :
5% 1-3% .

47

 .
.

,
.

.
,
, ,
(, , -'
, ). .
, ,
,
, , ,
, .
,
. , ,

. ,
(
, )
, ,
.

.

, , .
,
.
, : *
,
;
,
..

ACT; ; ; ?
.
*
, 5. -

49

.

( ,
..) ,
.
, :
,

. . 2 Child,
. ,

, ,
; ,
.
2
Child

( )

( )

200 /,
- 35 /
201 299 /,
34 31 /;

300 /; (5 - 30 /
.

.


.

'
.

,
(, ).
,
,
.
,
.

 , :
,
, , .

:
,
, ,
, . -,

, ,
1 40 .
: 1/250 1/300
.
.
,
:
;

.
,
6 .

,
.
(-,
, , )
, , ,
. , .

.

- .
*
.
-
- ,
, , . -*
*
^
.
^:

(. ).
?
, .. ,

 51

, -
.
-
.
,
, ,
-.
.

,
, ,
,
.

. .

. J&
.
, , ,
: ,
, p- ..

^^

=^=^


.

, .


.

(
, ..).



.
/
, ,

.
,
.
, ,

.

.
,
. .. .

 3

.

,
.
,

.

, ,
, .
(., 1997)

, ,
(White PF., 1989.).

, , ,
.

, -
,
. , ,
.
, ,

.


:
65 80%
(.. , 1998).
,
,
: , ,

. ,

,
(Pichelmayer, 1984).
, ,
,
, ~

^
(.. ., 2000).
,
-*
.' -
, 90-
(Davison J.K. et al., 1993).
, -
,
, ,

, .
,

.

:
3 /,
3 / ,
1 /,

.
,
(..
., 2000). --

,
, ,
. ,
Low
Minimal Flow Anesthesia, .
-;
-^
.

,
-*

I 55

-

.
.
,
, ,
.
( 3)
3

(J.Davison et al.,1993)

20

.
/
(37 )

243
175
239
664
157

2,3
1,8
1,4
0,42
0,69

/
(37 )
2,0
' 1,4
1,6

% .

0.74
1,68
1,15
6,0
2,05

1,7
. - , 50%

,
,
. .

,
,
/. ,
( > >).

.
(15% , 2% 0,2 % ).

,
(25% ).
.
( > >)

 ( > >).
- .
( >
>)
( > >), ,
. , ,
, .
,
(,
..), .
. -
*^

.

: ,
,
.
(
> >),
.
.
.
,
.
, , *
.
, ,
.
.
:
. - ( ) ( . . / / -,
. 1997 . - . 107 112.)

,
( ).
:
1. ,

57

(0,6-0,8 )
.
,

.
2.
(1,0-1,5 )

.

.

.
3
/ ( 1 / Minimum Flow Anaesthesia).
, ,
, , . ,

,
, .
,
.
.
7
,
- ,
()
; , ,
. ,

: , , .
, ,
, , ,
, .
, , ,
,
, ,
, (, ..)
.

( .. 1980, .., , 2003)
.

, ,
.

(

 / 0,6), ,
(Davison J.K., Eckhardt III
W.F., Perese D.A 1993). , ,
,
/
. , -
.

.
.

. (27 14*
, - 56+12 )
("", Abbott, ) 5 /,
(17 14 , - 54+11 ) - 5 /. 30 :
7,5 /. (;,
) 56+14 52+18 ^
;]
( .. 1998 .). , *-1
- Fi02 - 40%. *)
5,3+2,1 //;^
- 6,3+1,4 //. 1 ]
1 6,1+1,$
// ( 1C), 10 - ("", Abbott J
) 1,3 . *
, 40 - 45%<
( BJL, 1997)..
-*
"
2 (
. ., ., 1998).
:
,
5 ,
SpQ2.
Fi02 02
Fi 02 ET 02
Fi
( .. 1997 .)
:
1.
, 40 - 45% ?
, , , !
.

2. .
3.
.

t - .
+ .

0,7 %
.
2 %.
40 45% 3,2+0,5
(. 1).
3,3+1,0 .
,
2 . ,
, .
2 %
, ,
.

.
, /
.
,
/.
,
, , ,
, ,
.

, .

.
,
, ..
.
, , . 2.

. ,
1 -2
.
(, ,
.) .
, . ,

59


.
, , ,
() .
,
,
. ,
,
.
.

. 1.
: .

.
, ,
, ,
. , ,
( 12 ) 1,3
.

450 21
02.

(Eger E.I.,
1994).
, , -;
( .., .., 1999) ,
\
, -
-^
. -
.

II 61

.
.
(
) 25 -------------------------------------------------------------------------------------------------20

15

10

. 2. .
: *

.
70% . ,

,
30%.
60-70%.

.
.
.
60% .

,
.
FiN20 70% - .
- . ,

.
,
- ( .. . 1959.). , -

, N20 -, 12-
, , , ,

]2.


(G.D. et al., 1984).


,
.
,
' 4

. ,

.
.
- ,
,
.
-

.

I
.
, .

.

. *
. -^
. , '
.
^
. |

2-3 ,
^
|
. #
. ?
,
, , . -*;

I 63

,

. ( ..
. 2000).


,
. (Dwyer R et al. 1992; Eger El. 1994; Frink et al.
1992; Glass PSA, Hardman D et al. 1993.; ..,
.. .//
2000 - 1. - .45-50.)

.
:

;
, ;
, .

,
, -
, ,
.
, ,
.

,
,
, ,
.
( ),
(), ().

,
11, . 1932 . 1934
[ .., 1959]. , , ,

 ,
, ..
.
,
.
, - .
, ,
( ).

,
.
.

,
,
.
. .

.
,
2
.
. - ,
; ,
500 1000 ,
.
(pH 10),
(2,5% , ,
1% )
, .
30 . 80%
,
, ( 20-30
)
(, ). , - ,
, ,
.
,
. 3-12 .
, ,
.
,

. .

,
(
).
-
,
. ,
,
.
, ,

, .
2
.
,
(, - )
.
, (0,5-1,5 /)
.

.
, ,
.
in
vitro, in vivo, .
, (, ).

,
.
, , ,
, ,
.
, ,
.
,
.
,
,
.
()
,
N1. , , 2 ,
1000 . .

I 65

 .

, 34 ,
, .
.
, . ,
10 .
, ,
.

, .;
-^
.
,
.
(
,
). 1,01,5 / ( 80-150 )
. ,
57 . ,
1 /

.
(1 1%- 5 .).

2040 .
,
, , .

(, ) ,
?
. 1965 .
() ,!
, ^
*
(.. , 1993). :
(, ) $
( ); #
( , ).
; 2 $
( ); ?

67

.
(1,5-2 .
/ /),
.
, / ,
, 0,5 /.
1 / ( 2
// );
. :
0,5 / 2 ; 1,0 / 6 ; 2,0 / 10-15 .
,
. ()
, . .. .
(1995) , 0,5 /
.
( ) ,
,
.

, .
(

, , ,
) .

S ( +)-. ,
:
, ,
. 3>(+)-
;
.
,
NMDA
, .
S-.
,
, , . .
_ 0.1-0.2 /
. NMDA
. Roytblat .
, , -,

.
(eltanolon, coreltan) - .

68

. 2 3,5 //
: 1,39 1,21 /; tl/2?
0,025 0,028 ; tl/2? 0,66-0,65 ; tl/2? - 5,16-4,38 .
,
, ;
.
,
.
.

, ,
,
. ?1
,
,
. ( .,
., 2002).
(, ) 1965 . (
). (0,2-0,3 /
0,16 // ) TIVA (
0,005
//).
( 1
) 4-8
,
(
). :
0,2 / 2-3 , 0,3 / 4-5 .
,
, 1 .
;
;
, .
;
TIVA . .
:
( );
; , ( ); -
, , , .
-
.
1
;
.
:
!

I 69

(0,1-0,15 / 10 )
.
(
)

. '
.
, ,
(
,
).

. ,

.
() 1976 . ();
1993 . (2,6-)
- .
(
30-40 , ).
, , . ,
(
).

.

. ( 40
10 ) .
2,0-2,5 /.
,
,
.


. (
)
(, ). (Smith . et al., 1994.).

.

.
5%-
.
( 50-25 , ).


4 12 //.
, , ,
. ,
; , ,
. ,
10 // 8,6 //
65 .


2,97 / 4,04 /.

,
.
,
.
(, , N20 , , )
2,1 //.
(
) , .
150-200 //
100-120 / .

. ( .. . . . . ., ., 1998,27 .)


(PONV post operative
nausea and vomiting).
( ., . . - .:
, , 2002. 176 .).
,
,

: ,
.
.
,
,
. .
, ,
.
.

 I 7 1

()

(),
;
- ,
- .
,
.
- 1977 .;
-1- .
>
. , ( , )

.
,
(, , ).
, , , ,
; , -
(
). , 1956 ., (),
.
(, , , )
Stembach, Reeder I960 .
1964
;
2-4 . : ,
10 ( ),
, 2-3 (
- ). /
30 , 100 .
.
.
0,2
0,6 /,
.
,
5-7 . , ,

. ,
,
(
), - (

72 II 3
), (
),
, ,
. -,
(
), .
.
: ,
(
), .
. .
(, )
80- (, 1982). *
, .
25-30 ,
1,5-3,0 , < 1,5 .
(0,05-0,1 /) (0,15-0,2 /) . 60 . 0,15-0,2
/. ,
.
, ().
,

. ..1 . (1998),
15 - .
()
(0,06 /) .
(0,07 /) (3 /)
.
i

() ,
1979 .
80- . (500
5 1 10 ).
, , (
). / v
15 140 ( - :
60 ).
1 ( *
0,2 , 0,1 -
).
, ,
.

,

(, ), .

.
^^

, ,
,
-. -, -, -, -, - - .
,
:
1. , -:
.
2. ,
- -: , , .
3. ,
- -, , .
- -,
2-3 .

, . , - , .


.
.


.

.

. , , , TIVA.

73

 .
, 5-10
; 100 . 0,72 , 13,7 .
(92,5%), . ,
, . 10-20 /
. MAC
, .
. (Phitayakom . et al.,1987.).
( )
;
,
. *
,
- .
(Shafer S.L.,
Varvl J.R., 1991).
; 4 ,

. ,
, .
.
.
,
(5 /) .
(10-20 /)
(, 1,5-2 //
0,3 //)
.


(Meistelman . et al., 1987; Davis P.J. et al., 1997).

( 10 )
, . ^

**

0,5 //. *
, , *
(Glass RS. et al, 1993; Burkt H. et al., 1996).
^
,
TIVA, : *
- '
.

75

(). -
, (
) . , .
;
-2- ,
. ,
-
, 1/3-1/5
. 1 / 3 /,
(1 /), (1 /).
,

.

(-)
, , -
( ).
-,
( ,
).
.
, ,
(, , ), - ()
(TIVA). ,
-.

- ,
0 2.
; /
. (-6)
, . ,
.
- .

.
; ,

 . ,
.

( ).
.
,
: ,

, . .

- ().
(
), ( )
.

()
(). (, )
.
.
( )
, ,
(
). ,
.
;
: , ;
( -
). , ,
.
.
(. Freye,1987):
^^ ^
0,04 / ->1-2 -> j
12/ -> 0,04 -> 1-2 -4
-> < 12/, ->
> 12/, 30-45 / .

-j . ^
. *'

I 77

,
, .

, ,
, ,
.
, 5-10
, .
,

.
,
, .
10 (Ding Y., White P.F, 1995).
,
.
. ,

.
.

.
().

,
. (
- ) . -, , , (Aho ., et al., 1993).
, , ,
.
, .

,
.

,
, .
^ -2- (Kehlet ., Mather L.E.,
1992). -

 ,
. ,
-2 .
: ,

.
()
.

.
.
30- *
60%. -
.

, , '
-
, .
1 . ,
. ,
; -,
,
.
, ,
, . ,
, ,;
, .
,
. *?
, *
. *
^
^
.
if
/ () ,

.

, ^
:
().

I 79

()
() .

.
- ,
,
, , ,
.
,
, (, ):
,
,
. , , ,
,
- ().

(, , , ) ,
, .

,
. ,
,
,
, .

,

, , ,
.
,
, ,
,
, ,
.
( )
.
. ,

.
Savarese J. (1988)

: -

 5 7 , 20 ,
40 40 .
,
, (
),
( ) ( ;
95% ).

.
.
, ,
; ^
,

; ,

.

. , ,

,
, ,
, .
'
;
-!
ED95, .. , 95%

. ED95

.
, , ^
ED95. , 6 -1
. -
, ,
, , ,
-^
. ^
,
, ED95 , ^

#
. ^

^, , , .
.
- 30-40 .

. , ED95
0,4 0,5 /.
1 2 / .
, 4-6 .

,
(,
),
.
.

,
40 . ,
.
,
, ,
.
().
:
;
,
.
.

,
.

.

,
, 1 3000 , .

(
), .

- .
^
,
, .

81



,
.

.

:
1-5
( ),
.
,
,

, 15 60 .


-
.
;


,
- . :
*
,
.

*
. .
#
otf
/ .

.

, ,
. &!
:
*
.

, . , , 8,5 , . ED95
0,043 /, 0,06 /.
/ 0,08 0,1 / 1,5 2,5
, .
,
,
4 ED95, .

20 35 , 60 .
0,03 0,06
//.
,
.
(3- )
,
. -
- .
. . .
0,3 0,5 /
1,5-2 . 20 35 .
3 4
,
15 35 .
.

- .

. pH
7,40 ( pH )
,
20 .
,
( 6%)
. ,

.
.
,
, .
- .
(; Glaxo-Wellcome, ), , .

83

 ,
( )
.
2 .

, , ,
, 55 ,

.
.
.
, . .
,
.
,
. ED95
0,07 /, 0,1 /.
0,20 /,
22,5 0,15
0,10 /, 1,5 .
,
( 2,5 2 ),
95% - 20 ,
15 .
, .

, .
(). . ED95
0,3 /. 0,6 /
,

.
1 .
30 ,
50-70 .
.
.
, .
,
, .
(). .
. ,

. ED95 0,05'/. 5
/ 2
2540 .
, ( ,
,
),
- .
, . (Fukushima ., Ochiai R., 1995.

.
,

,
.
,
.
,
. , ,
, ,
.
,
.
.
,
, .
,
.
, ,
.
(
).
.
.
-
, ,

. , ,

85

 24 ,
, , 3040 , .
.
(Khali . DHonneur G., 1994), ,
,
.
12 .

, .
2-3 , (
10-15 , 8-10
). <
, ' .
.



.

(Basta S.J., 1992).

, ,
, ,
(Watcha M.F.,Write P.F., 1992).


.
.
,
. , , -;
, $
.
,
(, - 5- ),
30 50%
. 5-;
. $
, . '
. ,
(0.6 1.25 )
,
. *

> ,
,
, ,
. , , ..
, . ,
,
.
5-10
,
.
,

.

.
5- .
, ,
.
.

.
.

(Raider JC. 1991).
,
, ,

, ,

(Berdahl , Raeder JC et al. 1993).
,
.
.

,
. ()

(Dahl JB, Kehlet . 1993). (Dahl JB et al. 1994)

87

 .
,
, .

. . ,
2-4 ,
. ,
,
,
. 1,25-2,5 / -,
,
. ,
,
,
.
(Hickey R. Rowley CL., 1992),

, .

1. .. . .,
" , 2000.
-!
2.
.., . 1999.
3. .., .. .
, 2001.
4. . .
, 1998.
5 .1 ..

. .-, 9,,
1996.
6. / . .. .-.: , 1998, . 149-157.
7. .. . " *
. , N3/2000.
8. .., ..
. ;
1998.
;
9. .. ^
;
. ., 1996.
\
10. .. : ^
, , 1999 ., . 42-43.
*
11. . .
, . 1998.

II 89

12. . -., . .
: 1-/ . .-.-.: -
, 1998, .174-185.
13. .., .., ..
: .
, N4/2001.
14.
. ., 1998.
15. , . - .-.:
- ,2002.
16. ., ..
. " ,
, 3,19/
17. . - .
., , 1996.
18. ..
, ., , 1997.
19. ..
. , 2, 1996.
20. . Hart Diprivan: A Change in Formulation (correspondence) Eur J
Anaesthiol 17, 2000: 71-73.
21. D.LHerr, K.Kelly, J.B.Hall, J.UIatowski Safety and Efficacy of Propofol
With EDTA When Used for Sedation of Surgical Intensive Care Unit Patients
Intensive Care Medicine 26, 2000: S452-4.62.
22. Data on file AstraZeneca, Wilmington, Delaware, 2.
23. EAbraham, P.J.Papadacos, R.S.Tharratt Effects of Propofol Containing
EDTA on Mineral Metabolism in Medical ICU Patients With Pulmonary
Dysfunctions Intensive Care Medicine 26, 2000: S422-432.
24. F.Sata, S.Araki, KMurata, H.Aono "Behavior of Heavy Metals in Human
Urine and Blood Following Calcium Disodium Ethylendiamine Tetraacetate
Injection: Observations in Metal Workers" J Toxicol Environ Health 54,1998: 167178.
25. G.P.Zaloga, D.Teres "The Safety and Efficacy of Propofol Containing EDTA.
A Randomised Clinical Trial Programme Focusing on Cation and Trace Metal
Homeostasis in Criticaly III Patients Intensive Care Medicine 26, 2000: S398-399.
26. G.PZaloga, E.Young, D.Teres "Propofol-Containing Sedative Increase
Levels of Parathyroid Hormone Intensive Care Medicine 26, 2000: S405-412.
27. J.Barr, G.P.Zaloga, M.T.Haupt, M.Weinmann "Cation Metabolism During
Propofol Sedation With and Without EDTA in Patients With Impaired Renal
Function Intensive Care Medicine 26, 2000: S433-442.
28. J.Wahr, J.Vender Effects of Propofol With and Without EDTA on
Haemodynamics and Calcium and Magnesium Homeostasis During and After
Cardiac Surgery Intensive Care Medicine 26, 2000: S443-451.
29. K.A.Thompson, D.B.Goodale "The Recent Development of Propofol
(DIPRTVa N) Intensive Care Medicine 26, 2000: S40U-404.
30. M.Maze. "Sedation in the intensive care unit. International Congress and*
Simpozium, series 221, 1998.
31. TLHiggins, M.Murray, D.H.Kett "Trace Element Homeostasis During
^ontinuous Sedation With Propofol Containing EDTA Versus Other Sedatives in
Criticaly III Patients" Intensive Care Medicine 26, 2000: S413-421.


,,
,
, ,
. -
,

(Abeles G. . 2000).
,
,
.
'
,
.. .. ,
,
(Markland D. . 1993,
Kaufman . . 1995).
,
, .

, , ,
,
.

,
. ,
.

(Korttila . 1995,t
Saeger HD. . 1995).
'

:
;
;
!
() ;
, ,
;
;
(Anesthesia and Ambulatory Surgery (ASA, 1993)).

, ,
.
,
.
, ,
.

0000
1. ,


. ,
-
,

- .
2. ,

. , ,
,
. ,
,
, ,
EMLA, AstraZeneca, .
3. - ,
, ,
,
.
4. ,
, ,
,
, .
, .
5. ,

( ,
..)
3 5 ..
,
,
.
,
( ).

91

 - ^
, .


. , ..,
,
,
. , ,
, ,
.
, .. ( , -
..), -, ^4
.
, , ( )
, ,
,
.

(
) .
,

(Davison J., 1993)
6,
,
,

, ,
.
;
, .. hypnotic-based
anesthesia () ,
,
.
.
()
. , ,
.
,
, , ( ^
) , (
, ) . , , .
- *
(, ..) *

,
,

(, , )
.

. ,

, ..:

.


.


. TCI,
,
.

.

. ,
,
.
,
, /
(Prys-Roberts . . 1996,
Warden J. . 1996, Struys . . 2001). ,


(Scherpereel , 2001).

, -, 70- ,

,
,
. , ,
,
TCI.
, ,
, ;
. 1 , , ,
* -

93

94

, , ^
,
. ,

, , .
0,2 43 %% (Ruiz V. .
1998, Liu WHD 1991, Schierbeck J.c . 1997, Ranta S. . 1997,
Ranta S. . 1998, Heier . . 1996, Lyons G. . 1991, Tsai PS.
. 2001, Ranta S. . 1996, Bogetz . . 1984).

7 72%% (Schwender D., 1995).
, '
*
,
, ,
,


. &
. 5
Jeanet () - -'
, 1993 . -
(Awareness with Anesthesia Research EducatioiV
(AWARE)), , ^
, ^
.- '
, ^
, .. ^
; -|
, ,
.
-|
,

(), (BIS) *|
() *
. ^

|
. 11314 , *
. .. 1992 2001
:
1) :
2) ;
3) ;
4) (<|

I 95

, ) ;
5) .

BIS ,
, , ,
, ,
.

(3; 4 , , 2)
(1; 5).


(PONV).
,
(,
, ). PONV
.

:
() (),
(
) - . HJIA
(, , , )

. , ,

^,
(
-)
. . ,
.
(. )
.
, ,
. ,
. . ,
, . ( ) ,
.
,
,


.
(,
, , / ..), ,
,
( . . 200(f)
, . ,


.
, , -

, , , .


. (,
GlaxoSmithKline, ) ,
( ) (Esterase-Metabolised Opioid).
.
t
(t) = kie Je -ke('-v Ai (r) dr
, ,
.
.

. 1.1.
. .

based anesthesia.


. .. . *

.
.
, - :
;
;


;
;
;

;
- .
-
,

:
,
;
,

;
,

,
;
, ,
. ,

,
.


. :

,
, .

, .

97

98

^
,
,,
. .
, - ,
,

.
,
.
, .., ,
,
, , .

.
,
,
.

, () .
,
, ^
,
,
.
, -, -
.
7.
. ,
, ,
, ,
, -,'
,
, ;
.
\
, ,
, . .
, #,
,
, *!
/
, ,
, .
, ,
, .
'
1990 r.(Birch .
. 1990), ,

.
1020
,
.
, .

80- (Engbers .
2000, Engbers 1998, Engbers F. 1995, Gillham . . 2001, Glass .
. 1997, Graber R. 1999, Schuttler J. . 1983, Taylor I. . 1993).

,
,
, (Engbers
F . 2000, Gray J. . 1988, Hughes . 1992).

1.1, VI , . Segre Hull
et al. (Engbers F. . 2000).
(
) (
, ,
) (
),

.
,
, .
t
e-ke0t,
:
]
, kie
,

( . 1999, . . 2000, .
. 2001, Engbers F. . 2000, Whitwam J. . 1998).

, ,

99

, , . 1983
Schutter et al.

(Schuttler J. . 1983, Scollo-Lavizzari
G. . 1985, Target Controlled Infusion (TCI) in anaesthetic practice, pre
scribing information, ZENECA Farmaceuticals, new edition, 1998).

,
,
,
/
- (target controlled,
infusion, TCI).
*
TCI (Target
Controlled Infusion {TCI) in anaesthetic practice, prescribing information,
ZENECA Farmaceuticals, new edition, 1998):
;
;
,
;
;
;
- .

TCI- (STANPUMP, S. Shafer, , ; STELPUMP J.F.
Coetzee, . , ; FHM Engbers, ,
.),
Diprifusor TCI (ZENECA Pharmaceuticals,
) .
TCI-
,
(manually-controlled infusion), :
;
;
;

;
;
.
(Engbers F. . 2000, Vuyk Jc . 1997)

() (),
,
.
Diprifusor TCI
1996 . , -

, 4 ( .
. 2001, Target Controlled Infusion (TCI) in anaesthetic practice, pre
scribing information, ZENECA Farmaceuticals, new edition, 1998).
4
,
Diprifusor TCI
10

12

21

13

K31

0,119 1 14 -1 0,055 1 0,0419 1 0,0033 1

0,26 1

.

,
. (
Vial Medical Master TCI, ,
30 10 ),

,
. ,

. Diprifusop> TCI
,
, .
, , ,
, -,

. (Gray J.c . 1988,Kirkpatrick . . 1988) ,
,
, .
,
Zeneca Pharmaceuticals (
<<Diprifusop> TCI), , 4-8
/. 3-6
/ (Target Controlled Infusion (TCI) in anaesthetic practice, prescrib
ing information, ZENECA Farmaceuticals, new edition, 1998).
,
,
(Davidson J.c . 1993, Vuyk Jc . 1997)
50 ,
50%
.
.
Davidson et al. (1993), 50 6,0

101

/, 50 4,5 /. ,
(Engbers . 2000, Engbers F. 1998,
Whitwam J. . 1998) ,


:

,
.
,
( ),
( ),
,
.
,

(Funk W. . 1997, Smith I. 2001, Mulroy . . 1995,
Markland D. . 1993, Kaufman . . 1995, Stuth . . 1995).

, 1
,
k
.
1. .
2. / .
3. .
.
4. .
5. :
.

2, 3 4 .

.
-

'

. :

;
;
;
.


.
,
.
. ,
,(
.
,
,
. , () ,
. ,
,
. , ,
.


.
, .
,
, , ..

.
. ,

,
.

,

,
, ,
,

-
.
,
(Nagelhout J.

103

104

. 2001, Delgado-Herrera L. . 2001, Smith I. 2001, . 2002, Hodgson . . 2000 Liebelt . 1996, Smith I. .
1995, Dembo J. 1995, Lieblich S. 1995, Markland D. . 1993,
Kaufman E. . 1995, Bocian D. . 1992, White P. 1992).

1. Abeles G, Warmuth IP, Sequeira M, Swensen RD, Bisaccia E,

Scaiborough DA. The use of conscious sedation for outpatient dermatologic
surgical procedures. Demiatol Surg 2000 Feb;26(2):121-6
2. Anesthesia and Ambulatory Surgery (ASA, 1993)
3. Birch BRP, Anson M, Gelister J and Miller R A Sedoanalgesia A
Safe, Cost Effective Alternative to General Anaesthesia. A Review of 1.020
Cases.Br J Urol 1990; 66: 342-350
4. Bocian D, French S. Propofol (Diprivan)a new intravenous anesthetic
with applications for outpatient ambulatory surgery. J Foot Surg 1992 NovDee^ l(6):603-6.
5. Bogetz M.S., Katz J A. Recall of surgery for major trauma. Anesthesiology
1984;61:6-9
6. Davidson J.A et al.: The effective concentration 50 for propofol with and
without 67% nitrous oxide. Acta Anaestheiol Scand 1993;37:458-64.
7. Delgado-Herrera L, Ostroff RD, Rogers SA. Sevoflurance: approaching
the ideal inhalational anesthetic, a pharmacologic, pharmacoeconomic, and
clinical review. CNS Drug Rev 2001 Spring;7(l):48-120
8. Dembo JB. Methohexital versus propofol for outpatient anesthesia. Part
II: Propofol is superior. J Oral Maxillofac Surg 1995 Jul;53(7):816-20
9. Engbers F., Groen-Mulder S., Vuyk J. On the Stady and Practice of
Intravenouse Anaesthesia, Kluwer Academic Publishers, 2000.
10. Engbers F.: Target controlled infusion in practice. Eur J Anaesth 1995;
12(suppl 10):88-90.
11. Engbers F.: Practical use of Diprifusor systems. Anaesthesia 1998;
(Suppl. 1): 28-34.
12. Funk W, Horauf K, Held P, Taeger Anesthesia for magnetic resonance
tomography in neonates, infants and young children. Radiologe 1997
Feb;37(2): 159-64.
13. Gillham MJ, Hutchinson RC, Carter R, Kenny GNC. Patient-main-?
tained sedation for endoscopic retrograde cholangiopancreatography using tar
get-controlled infusion of propofol: a pilot study. Gastrointest Endosdl
2001;54:14-7.
J
14. Glass PS, Bloom M, Kearse L, Rosow C, Sebel P, Manberg P. Bispectralj
Analysis Measures Sedation and Memory Effects of Propofol, Midazolam,^
Isoflurane, and Alfentanil in Healthy \blunteers. Anesthesiology 1997; 86 (4):j
836-847.
I
15. Graber RG. Propofol in the endoscopy suite: an anesthesiologist's per-1
spective [editorial]. Gastrointest Endosc 1999;49:803-6.
16. Gray J.M., Kenny G.N. Development of the Technology for"

Diprifusor TCI Systems, Anaesthesia, 53 Suppl. 1: 22-7, 1988.

17. Heier T; Steen PA. Awareness in anaesthesia: incidence, conse
quences and prevention. Acta Anaesthesiol Scand 1996 C)ct;40(9):1073-86
18. Hodgson PS, Liu SS. New developments in spinal anesthesia.
Anesthesiol Clin North America 2000 Jun;18(2):235-49.
19. Hughes MA, Glass PS, Jacobs JR. Context sensitive half-time in
multicompartment pharmacokinetic modesl for intravenous anesthetic
drugs. Anes 1992;76:334-341
20. Kaufman E, rJastak JT. Sedation for outpatient dental procedures
Compend Contin Educ Dent 1995 May;16(5):462, 464, 466
21. Kaufman E, Jastak JT. Sedation for outpatient dental procedures
Compend Contin Educ Dent 1995 May;16(5):462, 464, 466.
22. Kaufman E, Jastak JT. Sedation for outpatient dental procedures
Compend Contin Educ Dent 1995 May;16(5):462, 464, 466
23. Kirkpatrick ., Cockchott J.D., Douglas E.J., Nimmo W.S.
Pharmacokinetics of Propofol (Diprivan) in elderly patients. Br. J.
Anaenth., 1988. v. 60, N2.p. 146-150.
24. Korttila K. Recovery from outpatient anaesthesia. Factors affecting
outcome. Anaesthesia 1995 0ct;50 Suppl:22-8
25. Liebelt EL. Reducing pain during procedures. Curr Opin Pediatr
1996 Oct;8(5):436-41 Smith I, Nathanson MH, White PF. The role of
sevoflurane in outpatient anesthesia. Anesth Analg 1995 Dec;81(6
Suppl):S67-72
26. Lieblich SE. Methohexital versus propofol for outpatient anesthesia.
Part I: Methohexital is superior. J Oral Maxillofac Surg 1995 Jul;53(7):811-5
27. Liu WHD, Anaesthesia 1991; 46:435-7
28. LyonsG, Macdonald R. Anaesthesia 1991; 46:62-4
29. Markland D, Hardy L. Anxiety, relaxation and anaesthesia for daycase surgery. Br J Clin Psychol. 1993 Nov;32 ( Pt 4):493-504
30. Markland D, Hardy L. Anxiety, relaxation and anaesthesia for daycase surgery. Br J Clin Psychol. 1993 Nov;32 ( Pt 4):493-504.
31. Markland D, Hardy L. Anxiety, relaxation and anaesthesia for daycase surgery. Br J Clin Psychol. 1993 Nov;32 ( Pt 4):493-504
32. Mulroy MF, Wills RP. Spinal anesthesia for outpatients: appropriate
agents and techniques. J Clin Anesth 1995 Nov;7(7):622-7.
33. Nagelhout JJ, Boytim MJ. Pharmacologic rationale for anesthetic
agents in ambulatory practice. J Perianesth Nurs 2001 Dec;16(6):371-8.
34. Prys-Roberts C, Gersh BJ. Effects of anesthetics and vasodilators on
aortic input impedance. Anesthesiology. 1996 Feb;84(2):478-9.
35. Ranta S; Jussila J; Hynynen M, Recall of awareness during cardiac
anaesthesia: influence of feedback information to the anaesthesiologist.Acta
Anaesthesiol Scand 1996 May;40(5):554-60
36. Ranta S; Ranta V; Aromaa U Acta Anaesthesiol Scand 1997
Mar;41(3):356-9

37. Ranta S, Laurila R, Anesth Analg 1998; 86: 1084-9

38. Ruiz V; Koo M Rev Esp Anestesiol Reanim 1998 Mar;45(3): 106-9

105

106

39. Saeger HD, Klug W. Ambulatory visceral surgerylimits and risks

from the clinical viewpoint. Chirurg 1995 Apr;66(4):297-302
40. Scherpereel P. Perioperative care of diabetic patient. Minerva
Anestesiol. 2001 Apr;67(4):258-62.
41. Schierbeck J; Laursen SB Ugeskr Laeger 1997 Jun 2;159(23):3567-7
42. Schuttler J, Schwilden H, Stoeckel H. Pharmacokinetics as applied
to total intravenous anaesthesia. Anaestesia 1983; 38(suppl): 53-6.
43. Schwender D; Klasing S; Daunderer M; Madler C. Poppel E; Peter
Anaesthesist 1995 Nov;44( 1l):743-54
44. Scollo-Lavizzari G, Steinmann E. Reversal of hepatic coma by ben
zodiazepine antagonist (Ro 15-1788) (letter). Lancet 1985; 1:1324-1325.
45. Smith I. Anesthesia for laparoscopy with emphasis on outpatient
laparoscopy. Anesthesiol Clin North America 2001 Mar;19(l):21-41.
46. Smith I. Anesthesia for laparoscopy with emphasis on outpatient
laparoscopy. Anesthesiol Clin North America 2001 Mar;19(l):2l-41
47. Struys MM, Vinck OE, De Smet T, Mortier EP. The man-machine
interaction. Acta Anaesthesiol Belg. 2001;52(4):413-8.
48 . Stuth E, Bohrer H. Current status of ambulatory pediatric anesthesia
Anasthesiol Intensivmed Notfallmed Schmerzther 1995 Apr;30(2):86-95
49. Target Controlled Infusion (TCI) in anaesthetic practice, prescribing
information, ZENECA Farmaceuticals, new edition, 1998.
50. Taylor I., White ., Kenny G.N.C. Assessment of the value and pat
tern of use of a target controlled propofol infusion system. Int. J. Clin.
Monitoring and Computing, 1993, Vol. 10, p. 175-180.
51. Tsai PS, Huang CJ, Hung YC, Cheng CR. Effects on the bispectral
index during elective caesarean section: a comparison of propofol and isoflurane. Acta Anaesthesiol Sin. 2001 Mar;39(l): 17-22
52. Vuyk J. Mertens MJ. Olofsen E. Burm AG. Bovill JG. Propofol anes
thesia and rational opioid selection: determination of optimal EC50-EC95
propofol-opioid concentrations that assure adequate anesthesia and a rapid
return of consciousness. Anesthesiology. 87(6): 1549-62, 1997 Dec.
53. Warden JC, Horan BF. Deaths attributed to anaesthesia in New
South Wales, 1984-1990. Anaesth Intensive Care. 1996 Feb;24(l):66-73.
54. White PF. Studies of desflurane in outpatient anesthesia. Anestl
Analg 1992 Oct;75(4 Suppl):S47-53
55. Whitwam JG & McCloy RF. Principles and Practice of Sedation. 2nc
Ed. Blackwell Science. 1998.
56. .. .
,
N1/1999.




, ,
- . ,
,
,

,
, , ,
,-
,
,
, .
,

, , ,
.

. ,
,


.
(ASA), ,
David Gaba
, ,
[Gaba DM, et al, 1994.].
:
(
- );
; .
;

, ,
, ;
,

1'

..... 1 '

"........ 1 ~...

......................

, (pH
,
, ..)*

-

.
, , ,*
***
(
) , - *
.

.
,

, , .
.

, , ,
,
.

.
II . ,
CS5, -,
ST
(. 1). ,
"
- .

, .

 .


.

.
,
, .

()
().
- ,

1. CS5 -.

11 II 5
........
.
......................

- . ,
,
, ,

,
,

(SVR).
,
( )
SVR, (HR)
() .
*
,
, 70%
.
(DPTI deastolic
pressure time index),
(. 2).
, ,
(, -
).

(=-) ,
t (AV)
().
, , ,
, :
AAfl=SV/CA.

. 2. (DPTI).

, .
.
,
, -,
( ..).
()
- ,
, .

.
,
,
:
=+1/3 (+).
, (
,
), :
Aflep=CO*SVR;

- ,
,
() .
(, )

.
(NIBP non invasive blood pres
sure)
. NIBP
,
.
, ,
, ,
.
. ,
.

.

()
. ,
, .
, .

111

112

! 5

, ,
.
,
.
,
.
,
.

,
.
, , *
**
, .

.
, ,
, , 70%

10 ...
,
. ,

. ,

, ,
.
,
.

. ,

34 ...,
64 ...

, (,)
, .
. ,

.
, !'
( )
:
.

*
'
;

 -
;
;
,
, .

()
(IBP- invasive blood pressure)
IBP
. , -
. ;
; ,

;


,
,
.

(Sp02) .
, .
,
. transmittance sensor, .
,
:
,
;
,

, .

,
.
, ,
.

......................... - ....................................................1,11

------- f--------------- '

1 '~

. , *
,
.

.
. -^
, - j

.
-%
, , ,
.
^
. , I
,
(
RHb, - MetHb, 0 2)
- (%SaO^
func).

, -;
. , -;
( ),
.
( ,
)
, ^
.
(
), .
, -
-,
,
. ,

, (),
. -;
, ;:
,
, ?
.
1
*"*
. :
,
. #

,
/.

.
,
,
.
.
,
, .



(. 3).
Sp02.

.
.
,
.

, .
,
,
, Sa02>90.

, , ,

, , ,


.

..
.
.

115

116 5

*
.

, , ;
, , ^
,
.

-
, ,
, . ^
,
, ,

.
,
.

(Fi02)
-*;
, -^

.
'
,
,
, , -
,

,
,
.
,
, 6V0
. ,

.
!~
21%.

Ini

, -
,
.

(..)
(%) 0 2 -.
.
.

(. 4).
I ( ).

, , 0 2.
II ( ).

, ,
0 2, .
III ( CD).
. , -
- 0 2
- . ,
D, 02
-
02 (PetCOJ 02 (EtCOJ.

--
EtC02
02
,
, 25 ... , EtC02 02
, PaCOg

Li
2

. 4. .

 ( )
.
IV .
D. ^
, '
( DE).
.

-;
,
:
;
;
;

.
,
- - ,

.

, '

EtC02
.
0 2 ,
;
, ,
(, 5).
,
,
.
,
.
(Carnal capnogram) (, 6).
EtCOz _

v .

Seconds
. 5. .

 (
(,
, ),

, (
).
,
, .
EtC02, ,
.
, .

, , 02,
- EtC0 2
'.

- ().
,
(NIBP),
(Sp02) ,

. ,
.

,

.
( ) ,
(. 7).
, EtC0 2 15
... .

. 6. ,
(Carnal capnogram).

120

EtC02
EtC0 2 :
0 2

,
.

(
,
);
0 2
/ .
*
,
EtCO^ , , ,
, ,
.

,

,
.
.
J.
- .

. ^
, .
EtC0 2 -*
0 2 (FiC02). 7

.

EtCO*

. 7. EtC02 - .

, ,
.
,
.

:
,
;

;

;
;
;
;
.

.
.

, .

,
.

.
,
,
.
,
, , ,
.

121



, ,

. ,
.
, ,
,
.
-
.

,
,
.
,
, ,
,
, ,
. -;
, ,
,
,
, ;
,
, -;
. ^
, *

.
,
, . *
, , *

, * ,
.
,,;
,
,
. *
*
,
. , -

123

,

.
, 160
, .

, ,
, , ,
. ,
,

,
, , .

,
.


.
, ,
,
.

,
.

(),

. ,
-
, 1
( * ) 50% . -
,
,
.
^

" 8 8 ^ 8 ^ ! = 8 ^ ^ " ................. = = ^ ^ = ^

,
.
,
, ,

.
.
,
. 1
, *
, 2 .

/


/ ,
.
,
.
,
, - '
.
- v
,
*
4-5 -
.
( *
), - ,
(. 8).
- ,
,
Step Down. - ;
10- 8 -6 ( 1/, 10 ,
10 //, 8 8 //, 6 //), ;
Roberts FL et al, ,
3,67 /,

;
.
, *

. 8.
. ,
, .
6 // 2 .,
(3 /) .

.
MIR (Minimum
Infusion Rate) / ,
.

^^ /^


, ,

Target Controlled Infusions
(TCI) ,
, "
( )
.
.
,
.
, ,
, -
,
.

125


(..
,
).

,
( )
( ) - ,
.
50%
, ,
, -1
, *

, ,
.
,
,
.
TCI .
, , :
TCI
, -
;

. ,
-;
.

,
.

- . -5
,
,
.
'Ml

. ,
^

I1127

, .

, .
: (
) .
,
, .
, ,
Ramsay 1 5 .
,
(. 5).
5

RAMSAY

I
II
III
IV
V
VI

, , .
, ,
..........
.........
, ,
.
,
.
,
.
, .

.

, ,
,

.

,
( 10 .).
(, , . .),
.
,

. ,
, , .

- -

 ,
(
, , , ,
..).

.


(),
,
-
( .., .., 1998).
*

,

Fourier
, .

,
( ) [Pichlmayr Y, Kunkel ,
1984; Frost , 1993; Rampil I, 1998].

(CSA compressed spectral array),

(. 9).
- ,

(spectral edge frequency - SEF), ( )

(95% - SEF-95; 90% - SEF-90; 50% - SEF-50
MDFr) . ,
SEF

SEF -
. SEF -,
-^
, -f*
. , ;
,
,
SEF,
. , (*,
) ,
, *

1129

,
.
SEF-95

10:31
350
5

18:34 10

18:35 5
18:36 200
18:37
18:38
10;39 45
FIN20 *0.5

. 9. (CSA)
95% (SEF-95)
.

, 80-
Aspect ,
BYSPECTRAL INDEX
(BIS). BIS
,

,
(Sigl J.C., Chamoun
^G., 1994). ,
100% 0 % (. 6 ).

13011 5
6

BIS
BIS%
100 - 70

70-60

.
.



:
;
;

60-40
<40
0

-
,
.
- Aspect, , :
Bispectral Index BIS .
BIS - ,
. , -;
, '
,
, , - *
,
. , BIS,
, *
, (. 10).
, ,

, .

,
. -^
BIS [ BJI ., 2002].
t

, ;
,

, . ?;
,
, *:
.
<

I 131

. 10. -
BIS (40 - 60%).

. ..
,
. ,
,
.
, ,
.
( B.J1., 1998;
.. ., 1996; .. 1998),

. , (
) .


.

.

- ,

 .

, ,
( 2 - , 2 -
),
,
.
.
, , ,

, -
, ,
,


. , -,
, ,
(, ,
). -,
(, 1
25).
,
, (,
500 50,0 1 5).
,
.

. , .
- ()
,
. ,

, . -,
-*
,
. ,
,
.

 -
(),
, ,
,
. ,
,
,
.
, , ,


. ,
, 5-
, .

(, ,
..)
.

,
, ,
, , .

.
. ,
.

.
, (
, ,
, - ),
.
.
, ,
.

:
;

2-3 , ,
, (
);
, ;
,
.

 ,
,
. ,
,
,
, .

. - '
, , *

, .

.
,
, .
, ,
, :
;

, , ,
, , ..

, ,
, , -,

, .
- 4
.
, , ,
;
'
, -*
, ;
.(
, ..)
;
, &*
;
;
- ;
;
;
*
;

135

,
;
;
;
;


.

. , ,
.

.

, .


( ,
). ,


.

,
, . V
,
,

.
,
. , ,
- ,
,
,
.

.


,
.
.


, ,
, -
.

.

.

.

, ,
:
<
,
,
- ,
,
-N IB P .
:
,
, ,
,
,
.

.

1. ..* .., .., ..

()
. , 1999; 1:3 - 11.
2. .., .., .. .
ByspectraMndex (BIS)
. . . 2002, 1: 49 53. .
3. .. . :<
( .
..). ., , 1998.
4. .., .., .. . -,
. ^
. , 1996; 4: 18 - 24.
5. .., .., .. . -

137

. . ,1995;6: 22 - 27.
6 . ..
. . . ... .
. , ., 1997.
7. .. . .: (
. ..) ., ,
1998.
8 . AitkenheAfl AR ( ). .
: AR, Smith G, eds ( , ).
. I. ., , 1999.
9. Feeley TW, Rosental . Monitoring in Postanesthesia Care Unit
and Intensive Care Unit. In: Saidman LJ, Smith NT, eds. Monitoring in
Anesthesia 3rd ed. Butterworth-Heinemann, 1993.
10. Frost EA. Electroencephalography and Evoked Potential
Monitoring. In: Saidman U , Smith NT, eds. Monitoring in Anesthesia
3rd ed. Butterworth-Heinemann, 1993.
11. Gaba DM, Kevin JF Howard SK. Crisis Management in
Anesthesiology. Churchill Livingstone Inc., 1994.
12. Ludbrook GL, Upton RN, Grant C, Martinez A. Prolonged dysequilibrium between blood and brain concentrations of propofol during
infusions in sheep. Acta Anaesth Scand 1999; 43: 206 211.
13. Mohrman DE, Heller LJ ( , ).
- . -, , 2000.
14. Morgan GE, Mikhail MS Patient Monitors. In: Morgan GE,
Mikhail MS (eds). Clinical Anesthesiology (1st ed). Appelton&Lange
1992.
15. Mori K. EEG and awareness during anaesthesia. Brit J Anaesth 42:
1153 - 1155, 1987.
16. Perrino AC, Feldman JJ, Barash PG. Noninvasive Cardiovascular
Monitoring. In: Saidman U , Smith NT, eds. Monitoring in Anesthesia
3rd ed. Butterworth-Heinemann, 1993.
17. Pichlmayer I, Lips U, Kunkel H. The electroencephalogram in
anesthesia. Berlin: Springer-Verlay 1984.
18. Rampil IJ. A primer for EEG signal processing in anesthesia.
Anesthesiology 1998;89:980 1002.
19. Roberts FL, Dixon J, Lewis GTR, et al. Induction and mainte
nance of propofol anaesthesia. A manual infusion scheme. Anaesthesia
!988, 43 (Suppl): 14 - 7.
20. Sear JW. effects of drugs given by injection. In: Taylor TH, .
Major E (eds), Hazards and Complications of Anaesthesia, 2nd edn.
Churchill Livingstone, 1994.
w 21. Sigl J.C\, Chamoun N.G. In introduction to bispectral analysis for ^
hEG. J of Clin Monitoring 1994; 10: 392 - 404.
22. Stanski DR. Monitoring for Awareness During Anesthesia. In:

138

Saidman LJ, Smith NT, eds. Monitoring in Anesthesia 3rd ed

Butterworth-Heinemann, 1993.
23. Swedlow DB. Respiratory Gas Monitoring. In: Saidman LJ, Smit^
NT, eds. Monitoring in Anesthesia 3rd ed. Butterworth-Heinemann,
1993.
24. Tino G, Grippi MA ( , MA).
. : Grippi
MA, (ed) ( ). . ., , 1997.
25. Tremper , Barker SJ. Oxygenation and Blood Gases. In;
Saidman LJ, Smith NT, eds. Monitoring in Anesthesia 3rd edl
Butterworth-Heinemann, 1993.
26. Vater . . :
AR, Smith G, eds ( , ).
. I. ., , 1999.

6.1.

..
(1955), ,
. , ,
, ,
( ..,1959).
,
, , ,
,
.

.
,
.
, ,
, , , ,
, , ,
,
.

,
( ..,1959).
, , ,
, , , ,
, .
, , ,

. ,
,
, , ,

,
. ,
.
,
,
,
. -!
, #
, ^
.
,

,
. ..

.

^^^^
.

/'

.
.
,
.

, |
, (), , ^
, , , *;
.

*
,
(. 6 )
**
:
( 6 .) ( .*>
..., 2002);
( 6 *1

6.1. .

40

,
40

^
^ ,
^

^
^1 >
^^

141

(Malton J., Edelist G. 1992);

( B.H., ..,2002);
(
5 1 .) ( .., ..,2002);
( .., ..,2002 );
(Malton J., Edelist G.,'
1992);
1
(Malton J., Edelist G., 1992).
,
, , (Malton J.,
Edelist G., 1992).
i
, ,
, . ,
,
8 (Warner
et aL,1989), ,
.

12- , , , .
. *

6 . , ^

, ,
.
-
.
.

, |
.
, ?
, ,
( )
. &

, ^
.
*
2- . $
*#
. 2- (#;
, ) pH ,
##*
(Kaller S.K., Evert L.L.,1993).

6.1. ...

143

,
, (
), .
:
;
;
;
;
;
pH ;
;
( ..,
., 1998).
,

( , , , ).

(100 ), (0,1 /) 10
10 , 3040 .
.

, :
14 ,
80 ,
ASA III ,
(
, ,
..),
(
) (
,
..) ( ..,1998).

^ ^ ^ ^


, , , . (0 ., . ,2002).
^ .

144 6
, ,
,
, ,
- .


.
- ;
, , - ^
, ASA III, IV .
()
**
, - ,

, . ,
/ 0.5% 0,5-1%
.

, , , ,
( .., 2001).
-
2-3 ,
,
.
,
,
.
,
, ,
.
/,
. ;

().
,
. , ^
:
,
(,
). , *
:
,
.

6.1. ...

(J.G.
Whitman, R.F. Mc.Cloy) ,

, ,
.
.
,
, , , ,
, ,
.
,
(), ().
, ,

.
-
, ,
,
.
,
, ,
(Sa02). Sa0 2
90%
(02) 60 mm Hg.
, Sa0 2
. ,
,

KpoBjH (02).
.

(J.G. Whitman, R.F. Mc.Cloy, 1998).

10

()

//
/

145



,
(
), ,

, ,
,

.
()
.'
( 20-50 ), ( 1,65-4,22 //) (, 2001)
TCI (
) ( ..,1998; ..,2001;
.. ., 1999)
1,23-3,71 /.

( ..,2001).

. *
, 0,5 /,
III Ramsay ( IV) .
III Ramsay
.
(0,25-0,30 /), 15-20 ,
.

50-100 .
200 .

, ,
.
,
30
( ).
,
,
.

, *
, (). 1976
*
(),

6.1. ...

2 ( ,
(, )
18 ). ,
(, ,
, ,
,
),
, ,
,
.
,

. ( .., 1998; .., 1998;
.. ., 1998;).

,
. 1-5 \
.
. ,
.
, ,
, , ,
(),
.

().
.,
.

1-2 ,

,
.

,
,


.
5% *
- 0,9% .
200 , 1520 . 6 Q
, (100 )

1 . 300 600 ,

147

148 || 6
,
. -'
.
,
,
,
.
1
, ,
10 / ( 200 ) 15 .
45
, 10 / ( 200 ) 60- ( 4 ),
50 / 1 .
.

,

(, )
, (
).

,
,
.

. () .
. , .

- ,
.

-
.
, , ,
,
.

. ,
3000.
, ,
:
,

6.1. ...

,
;



,
;

,
,
, ;
,
,
;
,

, 24

, (,

).
.

(/), , (Lignocaine) (J.G. Whitman,
R.F. Mc.Cloy,1998), (0,25-0,5% ), (0,5%
) ( ..,1991; ..,1999) . ,
, , .
/
. J.G. Whitman, R.F. Mc.Cloy
25 /.
, , ,
,
. 25-50 ((J.G. Whitman,
R.F. Mc.Cloy, 1998).
, ,
, 3 .
,
. ,
75% (J.G.
whitman, R.F. Mc.Cloy, 1998).
,
^ / , * (Temazepam) 10-20 (J.G. Whitman, R.F. Mc.Cloy, 1998), -

149

I 50 11
0 ,001 - 0,002 0 , 10,2 . per os 1
*
(J.G. Whitman, R.E Mc.Cloy, 1998).
, , /
30 . .
,
(
, , , ,
, .

).
(J.G. Whitman, R.E Mc.Cloy, 1998)
, - *
, .
.

.

()

, . .

:






().

, *:
, ,
. , #
,
, .
(, )
. *

, ^
, .

6.1. ...

, , , ,
, ..,

. ,
, : 25 / (J.G.
Whitman, R.F. Mc.Cloy, 1998). ,
, 100-200 / ,
, , ( .. ., 2000; ..,1999; .., .. .,1999; .. ., 2001).

30 50 . ,
,
. ,
,
, , /

. ,
()
.

.
,
. : ,
, -
, ,
(
.., 1987; .., 2001).

,
( ..,1999). ,

() .
(
)
.
:
, - ,
, ,

1 51

I52 6
,
( ,
).

1. . .
. , 1998.

2. ., .. .
() .
, 1999,1:3-11.
3. .., ..
.
, 1997,1:67-69.
4. ..
. - .
. . 1991: 192-200.
5. .., ..
. , 2001: 226-233.
6 . .., .. .:
, 1997: 172-193.
7. ..
, ,
.
, 1999.
8 . .., .
.
, 1998, 2: 60-63.
9. . -., .
2- .-.:
, 2000 .
10. / . . - :
.
. , , 1997
11. .., .. , ., .
-- *
1998 .
12. .. . .
1959 .
13. .., . .
.
2002, 6 : 41-46

6.1. ...

14. .., , .., ..

.
? 3, 2002: 41-44.
15. ...


, 2001 .
16. .., ...
.
, 1998.

17. . / . ..
. .
, , 1998
18. .., ..
. .: , 1998
19. ..
.: , 1998, 150-160.
20. ..
. ,2002,5.
21. . .., .., ..,
.., ..
. . 2000, 3.
. .7-10..4
22. .., .., ..,
.. : , ,
. , 1999,6: 19-22.
23. .., ..
.
1998, 5: 43-45.
24. ..
()
. , 1998.

25. .., .. .
. , 1999, 3, 12-15.
26. .., .. .
. 2002, 4:
29-32.
27. .., ..
* .
. . 1987, 113-118.
28. .
. . 1987,113-118..., .., .., .. . . 1998, 5: 9-15.

153

29. .. : ^
, , . ^
, 1998, 5: 4-11.
J
30. .., .. |
- -i
. CONSILIUMf
MEDICUM. 1, 2002:7-10.
1
31. .., .. -
^
. 2000 , 6 : 12-15.
J
32. .., .. . *
. 2002, 2: 23-28. i
33. .., . '.
. I. . . :, 1998, 396-414.
34. Cohen .., Duncan P.G. Does anesthesia conrtibute to operative
mortality? JAMA 260;2859,1988.
35. Davidson J.A. et al. Acta Anaesthesiology. Scand., 1993,37 458-64. j
36. Kaller S.K., Evert LL. Potencial risks and preventive measures for
pulmonary aspiretion. Anaesth. Analg. 77; 171, 1993.
37. Malton J., Edelist G. The risk factors of importance the patient;
Problems of Anesthesia 6(2): 193, 1992.
38. Pitt H.A Percutaneus Dreinage of piogenic Liver Abscesses. Wold I
Surg. 1990,14,4,492-498.
39. Van Sonnenbeig E., Wittich G.R. et al. Percutaneus Drainage of
Infected and Noninfected Pancreatic Pseudocysts; Experience in 101 cases*
Radiology 1989; 170: 3: 752-762.
40 Warner M.A. et al. Rate of preoperative cessation of smoking and
other factors in postoperative pulmonary complications. A blanded study oj
coronary artery bypasss patients. Mayo Clin Proc 64: 609,1989.
|
41. Whitwam J.G.& McCloy R.F. Principles and Practice of Sedatiofl|
Blackwell Science Ltd 1998.

6.2.

6.2.

..

(- , , ),
(, , ).
,
.

.

() , ,

.


, , , .

.

, ,
, (
.., .., .., .., 2000).
, , ,
.
, ,
, ,
,
, ,
.
, ,
.
,
' , .

155

156

---------------------------------------------------------------------------- ,
,
:
;

;
( ).


, 1
5 ., ( ).

( 2- .) ,
(
, ,
.) , ( )
, .
30-40 .
.
( 0,05-0,08 /
0,15-0,2 /),

( .., 1998; -., ..,
1998). ,
,
..

, ,
.
, , ^
0,05-0,07 /.
10-20 , #;
20 . ,
( , , ) ^

.
, , -,

.
I
, 70 &
:
;

6.2.

I 157

1.
2.

5,0
5,0
3. 20,0
:
1. 15,0
2. 5,0
3. 20,0

( 2 - )
, ,
.
, ,
, ,
.,
- .
, ,
.

.

( ,
, , ,
.)
, (Kenny G.N., 1996; Whitwam JG,
McCloy RF., 1998; B.A., 1998; B.B.,
.., .., .., 2000).

.

, , ( ..,
.., 1995; Whitwam JG, McCloy RF., 1998; B.A.,
.., 1999; Engbers F., Groen-Mulder S., Vuyk J.,2000).

,
( .., 1998). , ) ,
, ..
,
^, . ^
* , .. ^ ,
( .., .., .., -

168

' ' ....................... ........... ..... ' ............................ ....... ====3^8

., 1995; ., 1998; -., ., 1998). |

( siring in hand ),
( ~
).
30

. ^
( ) |
0,5 /. *
0,25-0,3 / |
10-20 . , ^
. |
.
)
,
, , *
.
, }
. , ?
, !
^
( .., 1998).

,
,
, ,
.

,
|
, , 1
.
^

, , .

(Whitwam JG, 1|
RE, 1998; ., .,1999; B.F
, 1999, 2000 ).
.
,
.
,
.
,
.
*

6.2.

I 159

III Ramsey ( ,
).
, 2,5-3,0
//.
, ,
1,65+ 0,53 //
( ) 4,22+0,18 // ( ,
).
2,5-3,0
// 5-10
.
0,3-0,5 / ,
.
,
( 0 ,2-0,3 /) .

.
5-12 ,
2,5-3,0 // 6-7
. ,
.
Target-controlled infusion (TCI),
,
, ,
, .

,
.
( Vial Medical Master TCI, ,
30
10 ),

, . ,

(Engbers F, 1995;
Kenny G.N.,1996; Whitwam JG, McCloy RF., 1998; Engbens F., 1998; By A.A. ., 1999; .., .. ., 2000).
,
III Ramsay,
2,3-2,8 /.
1,3+0,15 / ()
7 +08 / ( , ).
1 , .

,

.
.
,
TCI 512
, 67 , ..
.
.
.
-
( , ,
),
. *


() ,
-
. ,

.
,
, -j
.
(, , ) ^
1982
, ,
, *
!
. ^
,
.
I
, ,
, ,
(Birch R , AnsoJ
, Miller R.A., 1990,1991; .., 1998; .., 1998J
|
, .
.
*
, *
( 1-2 ) .
0,04-0,05 //
III Ramsay. #*
. "
#
,
, . 6

6.2.

,
.
.
,
. .
,
, 3545 . .
, ..
, ,
- .
22,5
.
,
1 5 .


12 3040 .
30 .

(Target-controlled infu
sion) (Whitwam JG, McCloy RF., 1998; Engbers F., Groen-Mulder S.,
Vuyk J.,2000),
TCI
.
(, , .)
,
.
, ,
,
.
,
.

, ..
(40140 .).

-
. , ,
, ,
, , ,
,
(McCauley LD, Gee KW, Yamamura HI, 1994; -.,
-., 1998; .., 1998).
( )
, ,

161

 .

,
.
,
.
.

0,1 / (
). ,
2,5-5,0
30- 40 . , 3-4
, ,

.
-;
( ) 0,07-0,15 //
1,5-2
, .

, ,
,
.
()
,
.
, .
, ,
, -,
, .

(Klotz U.,1998; ..,"
1998; .., .., ..,1998).
,
( 1-2 ) ^
(35-50 ). |
,
^

. ^
, $
,
, *
( .#'
1998; .., 1998).
1
" & |

6.2. .

( ),

, ,

, (
..,1998; .., 1998; ..,1998).

(
) .

(
,
.).
0,1
0,1 1 , 1,0 (
). ,

0,2-0,3 . ,
- , -,
, .

.
,

30- .
,
.

,
.
,
.
.

.
,

. ,
,
( ).

- ,
.
, ,

163

164 || 6

(-., .., 1998; Whitwam JG, McCloy RF., 1998;

.., 1998).

, ,

(Lund N,
Papadakos PJ., 1995; ..,1998).

-|
.
,
2
.
.

30 .
, ( 20-30 )
(, ).
in
vitro, in vivo, . ,
(, ). ,
, , -,
. , -.
, -i
(-., .., 1998; .., 1998).;
. ]
co-i
, .. "
(pH 10) .
, -|
2,5 % 1 % . |
, ,. ]
. -:
( 1,0 /).
^
, 1,5-2,0 //
. <|
-
. 1,0 //. ^

.
f
/ () ^
, ^
N1. *&
, 34 ,
, ^ #

6.2.

10 . ,

,
.

, .

(-., .., 1998;
.., 1998).


. ,
. 0,5 /
.
0,51,0 //.
3040 . .

,
.

(, , ) ,
.
,
.
, ,
.

, - .
,
.
, -
( ,
),

(Dachs RJ, Innes GM., 1997; ..,1998).

, , , , TbIX.
,
, ,
^ , .
,

165

 , ..

.


.

, .

7.

, , ,


*
.

(

.

+++

+

+++
+ ++

+++
++ + *

++++
,
+ +

+++

++++
+ ++ +

++

.
+++
++
++

+ + + ,,

+++
+++
,
+++
++

I,1-*
+ ++ +
++ ++
+

.+

. ,
,

+ + + + -
+ + + -
.4
+ + -
+ -
^
*
.

' iJi

6.2.

I 167

.


. ,
( 116III ),

,
.

.
,
.
50100 35 .
(
, Sa02 ).

(
). ,
,
2% - 1,52 / (
). 23 .

.
, 15 .

24 2,5 % -
,
.

.
, (, .). ,

1,01,5 /. ,
.
, 23 ,
2 / . ,
^ , 50-100
,


.
, ,
.
,


.

,

.
,
( .., ..,
1998).
:
.
,

, ..
. .
, 2 .,

(. ).
*
, *
, . .

.
.

- ,
.
(0,50,25 - ,
0,25-0,125 - ); (3,0-5,0 , 100-150
710 - ),
.

. -\
, , ,
.
,
,
, , ..
, ,

6.2.

. ,
40-60 2% 10-15 ( 0,5 % -).
(0,1 ) (25-50 ).
( ,
),
, ,
.
( .., .., 1998; -., .., 1998). ,
(
) ,


.

,
, (
), - (
).
.

, ,
.
, ,
.
: , ,
, .
.

.

^ ,
^.
,
, ( 100
10 ), (.
).
* 2030 ,

169

170

,
. ~;
, - *
.
.
^
^
, . ^

.
*

^
.
( 12 2,551
) (50100 ).
-
.
*
**
.
,
.
/
|
, ^
, . |
^
, ?*
.
, "
,
. , $
,
.
"

?
. , ^
- ^

, #
.
^
, , *^
. *
, ,
. , , !^
.
^
of]

6.2.

( 0,05 / 0,10-0,12 /) . .
.
,
,
( 25-50 ).

. , . , ,
( 1-2
0,02-0,05 //) .
.

.
. ,
02 .

, ,
.
,, .
.

. , ..
( .., 1995; ., 1998).

, , ,
.
,
.
, .

-
.

171

172

1. .. . 2- . , 1998 ., 1- ., . 411 - 424, 479 - 483.

2. ..
. .
. . .. 1997.
3. .., ...
-
. .
., 1995, . 9 - 1 5 . 214.
4. .., ..
,
, .
, 1998.
5. .., .., ..,
.. , 21
. VII .
.-.. 2000.- . . .158..1
6. .., .., ..,
.., ..
. . 2000, 3.
.7-10..4
7. .., .., .., ..,
.., .. ^
:
- 2000. 0 (). .25 - 33.9
8. ..,. . ,
1998 . .
9. .., .. (
) , Be*,
, N 1/1999.
:
10. ..
() ^
, , .
, 1998.
11. -., .. . 2~%
. , 1998 ., 1- ., . 175 179.
12. ..
/ /
. , 1996.
13. .., .. *
, 1998 ., . 117 - 122.
14. Amrein R, Leishman , Bentzinger , et al. Flumazenil in b e n z o d b
azepine antagonism: actions and clinical use in intoxications and anesthesb

6.2. I 1 7 3

ology. Med Toxicol 1987; 2:411 29.

15. Birch R P and Miller R A. Sedoanalgesia with Sedation Reversal.
Journal of Day Surgery 1991; 1.3: 5 - 6 .
16. Birch R P, Anson M; Gelister J and Miller R A. Sedoanalgesia in
Urology: Technique Applications and Impact World J Urol, 1989; 7:
17. Birch R P, Anson M, Gelister J and Miller R A. Sedoanalgesia - e
A Safe, Cost Effective Alternative to General Anaesthesia. A Review of
1,020 Cases.Br J Urol 1990; 66: 342-350
18. Engbers F., Groen-Mulder S., Vuyk J. On the Stady and Practice of
Intravenouse Anaesthesia, Kluwer Academic Publishers, 2000.
19. Engbers F.: Target controlled infusion in practice. Eur J Anaesth
1995; 12(suppl 10):88-90.
20. Kenny G.N. Patient sedation: Technical problems and develop
ments, European Jomel of Anaesthesiology, (Suppl.) 1996: 13, p. 18 21.
21. Miller R. A Ten years of sedoanalgesia and how it has affected uro
logical practice. Arch. Ital. Urol. Androl. ,1997, vol 69, p.29 - 33.
22. Miller R A, Birch R P, Anson M, Bell J, Gelister J and Grant D.
The Impact of Minimally Invasive Surgery and Sedoanalgesia on Urological
Practice. Royal Postgrad Med J, 1990; 66: (suppl) 572 576.
23. Miller R A, Gelister J, Lei C, Parker C, Anson M, Grant D and
Birch R P. Advances in Minimally Invasive Surgery of the Prostate. World
J Urol, 1989; 7:158-161.
24. Short TG, Maling T, Galletly DC. Ventricular arrhythmia precipitat
ed by flumazenil. Br Med J 1988; 296:1070 - 71.
25. Taylor E, Ghouri AF, White PF. Midazolam in combination with
propofol for sedation during local anesthesia. J Clin Anesth. 1992;4:213
2 ! 6.

26. Whitwam JG & McCloy RF. Principles and Practice of Sedation. 2nd
Ed. Blackwell Science. 1998.

6.3.

..
,
-;
, ,
. ]
,
, -^
,
.

,
.
,
.

^
>^
.
>
F
|
(, *
), *
*
.
\ ^
. .. ^
^
3- ,
V:

|
, *
- ( - 1^
)
.
( Of
coff5
).

if

o6 b w
. ! # !
-

6.3. I 1 7 5

.
,
, ,
.
.

,
,
. ,
,
.
-,
-
.

.

, ^,
1-5 ( ).

.

,
- .

, ..
.

. ,
(20%
),
.

.
.

.
, ^

.
.

( .., . .., ..,

2000).
( .., .., 1995; ..,

1 7 6

6
"

' '
-41
.., 1998; .., 1998; ). ,
, ,
;
,
-
( .., 1995). ,
.
(Murphy P.G., Myers D.S., Davies P.J. et a l, 1992).
,
(), .
,
(Breheny F.X., 1992; -*
.., 1998; .., 1998).

.

, ,
6
30-40 (Breheny F.X., 1992; .., 1998;).

- ,
(
),
. ,
, -
( .., 1998; -*|
.., 1998).
\
^
, .. *
.

,
. ,
! \
........................... .........................................

?*
, ,
, |
.. *

(, !
, <|
, ). ($

6.3. 11

177

, )

.

.
.
>

. ,
, , .. 100%
,
.

-
,
(
). ,

.
,
,
(
).
.
.
.
, .

(
).
, .. .
- ( 0,1 /).

.


.
, , .
10 . 10

.
, -

17811 6
. 68 /, 0,08-0,10 / 0,5 .
0,15-0,20 /. '
, -"
( 1,0 - 1,5{
/) (0,05 /), (0,1 /) :
(Pruitt JW, Goldwasser MS, Sabol SR, Prstojevich SJ.l
1995; Dachs RJ, Innes GM., 1997).
^
, , ^
.
j
, <$|
!^
.
,
(.
). * -J
, :
( .., ., 1999; -;
.., .., 1999; Nug ., Taddio A., Ohlsson ., 2000) ;

. ,.
$
,
, |
.
'|
, I
$!
. 1#|
, #
.
I
|
.
'
'
, ,
, ^5

. ?
, , 10
( ) &
,
. #
, *
.
.

6.3.

179

.
,
.


.
, ,
.

- ,
, .

1. .., .. () ,
, N 1/1999.
2. .., ...
()
, , N 1, 1999.
3. .., . .., ..,
..
..
1999. 1- . . 2000 . . .32-33..
4. .., . . ,
1998 . .
5. ..
() , , .
, 1998.
6. ..
,
,N4/1998.
7* ..
: ^, . , 1995 .,.
8.

.., .. , - .
, . , 1998.
9- ., ...

 - '
.
., 1995, . 9 15. 214.
10. .. . 2~. *
, 1998 ., 1- ., . 411 424, 479 483.
4
11. -., .. . 2-fc
. , 1998 ., 1- ., . 175 179.
I
12. Dachs RJ, Innes GM. Intravenous ketamine sedation of pediatrics
the emergency department. Ann Emerg Med 1997 Jan; 29: 1, 146 50. |
13. Pruitt JW, Goldwasser MS, Sabol SR, Prstojevich SJ. Intramuscula|
ketamine, midazolam and glycopyrrolate for pediatric sedation in the
gency department. J Oral Maxillofac Surg, 1995 Jan; 53:1,13 7.
*jj
14. Murphy P.G., Myers D.S., Davies P.J. et al. The Antioxidaif
Potencial of Propofol. British Journal of Anaest. 1992; 68: 613 18.
I
15. Nug E., Taddio A., Ohlsson A.: Intravenous midazolam infusion fo|
sedation of infants in the neonatal intensive care unit. Cochrane Database
Syst. Rev.: 2:CD002052, 2000.
1
16. Kumar S.S., Viitanen H., Annila P.P. Premedication with midazolarij
in pediatric anesthesia. Anesth. Analg., 90(2):498, 2000 Feb.
q
17. Breheny FX. Reversal of midazolam sedation with flumazenil.
Care Med 1992; 20:736 - 9.

6.4. ...

II 181

6.4.

..
,

.


,
- .
, ,
, . ,
, ,
( Jly ., .., 1982 ).

,
. 5
: , , , .
(,
, )
.
,
,
.
.
(, , ,
) (, , , ).
, , .
.

,
.
,
,


; ; ;

182 6
.... .......................... ................. ......................
...................
--
, *
,
, ^
,
;

, . |
j
, |
;

; o6ecji
,
; ]

!
( .., .., 1982 ).
%
$
; <1

.
4

]
.
,
, : 10 j 5rff
, ]
0,5 . *
10 |
, 0,5 0,1%
, .
, *
, .
(, , .)
, .

, #<|
, ^
. BMfift
.
*|
. , ,
, 2-^;
( ., .., 1982).
5
, ?
,

6.4. ...

II 183

.


1 0 , 1%
() 0,5 3% .



. ( )
,
.

,
.

,
.
,
,

.

, ,
.


, .
10 2 % .

,

( , ).
, ,
(
). ,
,
(
2 / 200).
,
* .


-
. , * ,

1s

,
.
. *

.
9 ,
, (
). ( ., ..)

,
.
-
, ^
*
*
*
.

.
,
,
2
- ( ^
) 25.


.
^
2%
1 , !*
#
,
H epB f
, *#
,
( n. Frenicus *
).
>
<
:
( ),
, *

, 4 4% '
.
. "
*
,
, *?.

.4. ... 11

.
,

.
( Roberts
J .T - 1991; Duvall A.J., 1980).

,
90- . ,


,

( . ., 2001;
.., 1999).

, .
( ),
.
?-1 .
,
. ,
,
.
, ,
- ,
.


.

, ,
, ,
, (,
).

(
0 ). , ,
, .
, -

185

 ( .., .., 1982;|

Benumof J.L., 1995 ).

,
( , , ^
, , ^
.). *|
*!
, ^

. ( |

2 4 /2. ,

.
, \
, |

,
. 60 , ]
100
. , !

<
.


,
.
:
2-3 .;
,
;
;

.
, i

. :
,
^!
. ,
, . i
,
(
).

6.4. ...

II 187

/2 , 110-120
: 1 : 2.
2,5-3 /2.
,
.
,
BBJI, 25%
.
.
,
.

.

.

,
.
. ,
,

, .
-
. ,
,
, ,

. 30 40 .

. ,
, ,
( .JL, .., 1997; Kaplan J.., 1991).

I. .., . . .
, 1982.
. 2. B.JI., .., . . :
, 1997.

3- . - ., . . . : 2000.
. 4. .., . . - :
1989.

188 6

'
*
"
"
'
-ffj
5. .., .. . - 4

// 3 2001.
6 . .., .., .. . / / - ,
/ / 1 1999.
7. .., .. / / 7 1993.
;
8. .. / / / / : 1999 >
.1.
}
9. .., .. . - *
/ / *
/ 1 1999.
^
10. .., .., .., ..,4
.. - ae!$j
/ /
// 1 1999.
11. ..
/ / / / 1 1999.
12. .., .., . -'

/ / / 6 1994.
13. ..
.^
. . . . ., 1997.
14. . ., ..
/ / -
/ / 1 1999.
15. Benumof J.L. Anesthesia for Thoracic Surgery, 2 nd ed. Saunders,*
1995.
j
16. Brodsky J.B. Thoracic Anesthesia. In: Problems in Anestesia, 4: 2*
Lippincott, 1990.
J
17. Cohen E. The Practice of Thoracic Anesthesia. Lippincott, 1995 /
18. Gravlee G. P., Rauck R. L. 'Pain Management in Cardiothoracid
Surgery. Lippincott, 1993.
19. Kaplan J. A. Thoracic Anesthesia, 2 nd ed. Churchill Livingstone,
1991.
20. Roberts J.T. Fiberoptics in Anesthesia. Saunders, 1991.
21. Benumof J.L. Management of difficult adult airway with special
emphasis on awake traheal intubation. Anesthesiology, 75: 1991.
22. Carden E. Recent improvements in techniques for general anesthesia
for Bronchoscopy. Chest, 1978.
;i;
23. Duvall A.J., Jonsen A.F. Bronchoskopy under general anesthesia
using the sanders ventilating attachment/ -Ann. Otol. 1980.

6.5.

II 189

6.5.

..
-
, ,
.
1. (

).
2. ,
. .
3. .

,
-.
- ,
.

: ,
, ,
, .

.

, .

,
,
, -
, .



.

.
, ^ , *
.
^,
3"3 ).

19011 6
-4
. , *
, (
).
|
^
- ,
,
(, ^
-, ).

, -:

( . , *
, ). (Weston G. Et
1985).

0[>
, ^,
,
. ; *
,
.

, ^
.
. |
;

.

, , ,
,
().
|
.

,
.
t
,
,
^
. ,
, (
$|
. ^##!
( ),
( ). #

.5.

II 191

,
.

6 ,
;

. ( ..,
..; 1997).

, 30 .

( ., 1989).
,
, .

, ,
,
( .., ..,1994).

, ,
, ,
.

, , , , , , . (White P.F., 1997).
,
,
5-15
.
, . () , .

, ,

,

,
.
^, 1,5 , 20
( ),
. -

192 II 6
'

......... -

'

..................

^4

,
, .


.
.
, ;
, ,
, ;
, *
.
, ,
-!
.

, , * ,
, ^


,

.
,
,
, , , .
^
. ( .. ., 1998; Xappfj
.. ., 2002)
,
*?

, ,
!$
- ( )^
. ( #
), (
)
( 02).
( ) ^#?
, BPf
.
,
|
15
. ^!
- *?

6.5.

. .

, ,
. .

.
.
,
,
.
, - ,
.
,

. ,
, , , .
.
, , , ,
,
. ,
,
, .

^
,
.
, ,
. ,
,
.
JIOP-, -
.

.
0*
^ ,
, ,
, , . -

193

194 6
- 0

.... :........................... .. 1

" - .......... ..

, "
. -,
,
;
.
, -<
, ?
. Me- J
in vitro - i
. -*
- i
, ^
|
.
i

" '

.........

1. .., .. -;'
. , 1997 396 .
2. .., .., .., .., -</
.., ..
. ., X, 2000. 384 .
3. .., .., .. / / . ;
.- 1989. 3. .37-39.
^
4. .., .., .. //. |
. 2002 , 1.
f
5. .., .. , , . ., 1994i|
6 . Weston G., Strunin L., Amundson G.M. Imaging for anaestetists:
review of the metods and anaesthetic implications of diagnostic imaging?
techniques. / / Can. Anaesth. Soc. J. 1985, 32, 552/
^
7. White P.F. Update of Anaesthetic Methods in Outpatient Anaesthesia.
5-th ESAAnnual Meeting. 1997. Refresher Course Lectures. P.255-262,:

_______________________________________6.6.

195

6.6.

..

:
,
,
,
;
, ,
,
.
ASAI-II
. ,
,
.
:
ASAIII-IV,
,
( Whitwam JG, McCloyRF 1998).

.
.
.
.
.
.


, .

,

, ,
.
, ,
.
,
1 ,
. ^ ,

196

,
.
,
,
,
.
, .
(
),
.
, . -*
- . (Church J 1991)
:
2 ( 1) 30 , 90.
.
, , ,
. 1 30 .
.
10 . ( , , ). ,
,
.
: ,
.

20-30 . *
^
.
^
:
. *
(Rood J , 1
J 1990)
41
\
(N.OI
*
, *;
, . |
, , %
. #^
- . N20 *
1. N20 10% , 20%
,
5%, 30%. ^
20-40% N 20 ,
10 6070%. 10
, , tffl

6.6.

I 197

, . (Simmons , 1989).
:
, ,
, .

.
N20
.
:
,
.
N 20 ,
. (Seward G R 1990; Whitwam JG,
McCloyRF 1998).
.
(, )
1
, .

.
: 30 .
: ,
N 20.
: - .

- .
.

. (Department of Health 1991
London).
.

, -

. ,
, ,
.

,
. (, ).
, , ,

----- --------- ------------- ------ ------- *....-................

, ( ,"
2000).
,
. ,
, ,
, ,
.
. ( B.A.V
2000; Royal College of Surgeons of England, London 1985)

,
.
,
, .

1. Professional Condukt and Fitness to Practise. Amendments of para

graphs 17 28 approved by Council in May 1996. General Dental Council,
London.
2. B.A. 2000.
3. Church J A Pollock J S S, Still D M, Parbrook G D 1991 Comparison
of two technigues for sedation in dental surgery. Anesthesia 46: 780 782 ;
4. Commission on the Provision on Surgical Services 1985 Guidelines foi
day case surgery. Royal College of Surgeons of England, London
5. Department of Health 1991 Report on an expert working party on gen?
eral anaesthesia , sedation and resuscitation in dentistry. Department oO
Health, Dental Division, London.
6 . Simmons M, Miller D, Cummings G C, Todd J G 1989 Outpatient
peadiatric dental anaesthesia. A comparison of halothane, enflurane afltcf
isoflurane.
*
Anaesthesia 44: 735 - 738.
7. Rood J P, Healy T E J 1990 The dental day case unir. Clinte&l
Anaesthesiology 4: 799 806.
r
8. Seward G R 1990 the use of nitrous oxide-oxygen inhalation sedation
with local analgesia as an alternative to general anaesthesia for dental extjrac*
tions in children. British Dental Journal 168: 467 - 470.
9. Whitwam JG,McCloyRF Principles and Practice of Sedation 188
197,1998.

6.7.

199

6.7.

..
, ,

.
,
.
, 1 ,
1 . -
-
, .

.
10% 2,5 7

, (Abel ., Friedburg .1987; .3., ,
1977). , :
, 10-12 .(3. Cote J
, 1993).

, 6 //,
, . -

, .

,
,
.
, .
: 4
5-6 .
, , U. ( 49 ), ,
* ,
.
;
,
. 4-5 .

-

 , 1
.
, ..

, %
. 10
.
.
-

,
. , !
1 10
. /2 + 12

:

, ,
. ,
/ ,
.

.
,
.
/ ,
*
.
, )

.
, ,
. -*

24 .
;

.
.
, ^
, , ,
- (.. , 2001).
'

6.7.

201

-
(
) 30 60%
.
,
,
, , ..
. ,
(170 200 /)
,

.
2-3 ;
, 110 /.
, 1|
130 /
100 / 6 .
,
,

.

( -
). ,

.
,
.
3 12 .
(.. , 2001) (. 1).

^

,
. 12 .
, . (.. , 2001).

.
40%
20% . 2 .

,
,

202 6
' ................. - 4

. -;
.

. ^
: 4 / 10 , 2 / 10 1 /*;;
20 .
*
,
. !
-?
. , nptjj
5
. , 30% ^
70% 5% , ^
.
4% 0.18% .(Lin R. 2001)
. , ,
,
, - . ,
.
,
, . ?
,
. ?
, . *

: , ,
^
. (Lin R., 2001.)

1
5

//

. ...

65

90

95

95

120

140

120

120

100

70

, /

85

80

80

75

7Q

-------- \
/

170-200

110

120

140-J

130
------

- J*

6.7. ||

.

,
.

, , .
,
10 // (..., 1997; Lin R.,2001.)
.

,
.
5%. , ,
, 10%
. ,
15% . ,
, ,
10 /. , , , ,
, ,
.
(.. ., 1997; Lin R., 2001).
.
-
(. . 7). 0,25 ( 8_/),
20% .
(,
) .
.
() .

3740.

.
.
, .
, :
, .

bbITb . 101 ,

203

204 6
, .

,
, . ,
3 ,
, .
;
, .


. ,
,
. !

, ,
,
.
,
;
.
.

.

.
(,
) ( ) (..
, 2001; Lin R., 2001).
/

^^^
,
.

( , *
, ). , ?
10% 22% .

(),
50% . ^
. #
,
.
, . , |
0.87 1.2 ^
. 3 0.9 ^

6.7.

, 0.76.
.

; ,
,
/ .
, 30%
, .
,
-
.
,

, , . (.. , ..
1999; Lin R.,2001r).
-
.
,
. ,
,
.

( ), 5-10

.

, ,
(Morgan DE ; Mikhail MD 1998.).
. , --
.
, ,

. - 0.76%, 243 ..

.

.
, 02.

. ,
,
^ 10 /.
.

205

206
( ?
). ,?
, . !
. ,
, -|
~|
. , -|
, -!
.(^ DE ; Mikhail MD 1998.). ^
, ~;
, . ^
%|
,
.(Morgan DE ; Mikhail MD 1998.).
; ,
, .

, . .(31.Morgan DE ;;
. MikhailMD1998.)
j


/.
, -5
, (Morgan DE; Mikhail MD 1998),
(. 8).
>
.

(%)

(Alan 1996)

.
0 -
3

. 1,08
0,9
0,76

1,35
1,3
1,15

9,0
1
8,0
J

2,0

1,9
1,7-

^1

~~



, &&
. #|
6 , |
^
. ,
5-7 / ?'!!
3-5 / .(1 R., 2001).

6.7.

207

,
.
;
, ,
,
.
, . 2-5/ ,
, . ,

.
MHK>.(Morgan DE; Mikhail MD 1998; Lin R., 2001r).
He .
,
. 1-2
/ ,
. ,
, .
- ,
;
. ,
, ,
.
. ,

, .

0.02 /.

510 /. (.. ., 1997).
.
, . /
0,2/ , 0,5/.
- 0,10,2/ / / ; 0,5/
. 0,5/ ;
2// /. (.. ., 1997).

^, .
*
<1

208

. , -
,
.
, , :
0.02 / 0.01
/ 0.05 /.

2-/
1,5/ . -
.
,
^
(Rylance G., 1981).
J

, , , ,
, ,
.
, '
. ,'
/*
-
, . ;
. 4
. 1 4 -;

,
. , *
, :
. (American
Academy of Pediatrics Committe on Drugs, 1992; Royal College
Anesthetists and Royal College of Radiologists. 1992r).

,
,
;
; ,
.
v'
, '
, . *
; "
; *"
*, ^
, <#|
, *^

6.7.

209

,
,
,
. ,
. (Royal College of Anesthetists and
Royal College of Radiologists, 1992r;.Snodgrass WR Dodge WF.,
1989;.Napoli KLc , 1996; Graff KJ , 1996).

.

-
-:



. - ,
, , , ,
100% ,
.
.
- , ,,
.
20
. ( Saint-Maurice
, 1986.)

.
: ,
,
. ,
,
, ASAI-II.
ASA III-IV,
. ,
,
6 .
^ 4 .
, ,
2 .

, * 6 .(.1 ., Friedburg , 1987.).

210
.......

Per/os:
. , , ^
30-60 ,
.
Per/rektum: ,
, . -"
(, , ). (Saint-Maurice;
1986).
.*

, , , neper $
. , !
..
:
per/os, , .
.
: ,
.
j
:
. 8

(.. , 1997)

,

*

- ?
.
\ '*
**
\
;
, - ?
-'
.
j?
^

i \

, ^
(
j
) ;;
; $ ;
^ .
.
.j :
+ ; ^

, , ?!
/ *
.

6.7. 2 1 1

,
. (Lord WD, 1996.).

:
.
5 .
(. 8, 9, 10).
. 9

(Whitwam JG, McCloy RF, 1998 .)

per/os

50 - 100; . 2.

> 60 .

0,5-0,75
0,5-0,75
0 ,2 -0 ,4
0,1 -0 ,3

30
20
10

1-2
1
1

Per/os

Per/os

30
20 - 30
1 - 2

>2
>2
> 30

0 ,5 -1

15 - 30 ; 1
1

> 3 -4
> 4

1 - 5/

1 -4

> 30

0,1 -0 ,3
0,2 -0 ,3
0,1 -0 ,3

/
Per/os

10
/ .

(.. , 1997)

.
^

5 - 6 / , 2 /

2 - 3 /
0,02 /
1 - 2 /-/; 3 - 5 / /. ;
8 - 1 0 / / ; 8 /
0,1 - 0,3 /; / 0,1 - 0,3 /
0,5 - 0,75 /, / 0,5 -1 /; / 0,5 - 1 /
40 - 50 /; 30 /
/ 0,1 / ; / 1 - 2 /.


1. Abel ., Friedburg . Medication und uberwachung junger padiatrische patienten bei NMR untersuchungen.// Anaesthesist. 1987. Bd. 36
s.137-139.
2. A.3., B.H., .. .// .: .., ..
. .. 1977. .215-227
3. Cote J, Ryan J F, Todres ID , Goudsouzian N G 1993 A practice of,
anesthesia for infants and children. W Saunders, Philadelphia.
*
4. Lin R. ,
2001.
5. Textbook of Anestesia ; edited by Alan R. Aitkenhead, Graham Smith;
third edition 1996.
6. American Academy of Pediatrics Committe on Drugs. Guidelines for
monitoring and management of pediatric patients during and after sedation
for diagnostic and therapeutic procedures. Pediatrics 1992; 89: 1110-15.
7. Royal College of Anesthetists and Royal College of Radiologists.
Sedation and anesthesia in radiology. Report of a Joint Working Party, 1992.,'
8. Snodgrass WR, Dodge WF. Litic/DRT coctail: time for rational and
safe alternatives. Ped Clin North Amer 1989;36: 1285-91.
9. Napoli KL, Ingall CG, Martin GR/ Safeti and efficacy of chloral
hydrate sedation in children undergoing echocardiography. J Pediatr 1996; 4
129:287-91.
:
10. Graff KJ, Kennedy RM, Jaffe DM. Conscious sedation for pediatric^
orthopedic emergencies.Ped Emerg Care 1996; 12: 31-5.
11. Saint-Maurice C, Meistelman C, Rey E et al. The pharmacokinetics ;
of rectal midasolam for premedication in children. Anesthesiology 1986; 65;
536-8.
,
/;
12. Phillips S, Dabom AK, Hatch DJ. Preoperative fasting for paediatric ;
anesthesia. Br J Anesth 1994;73: 529-36.
$
13. Lord WD The Sedation of Children;Whitwam JG,McCloy RF;
Principles and Practice of Sedation 188-1971998.
i
14. .. , C.M. , B.A. ;
- ...
*
1997.
15. BrounTCK, Fisk G 1991 Anaesthesia for children. Blackwelt
Sccientific Publicacions, Oxford.

16. Rylance G 1981 Clinical pharmacology. Drugs in children. British

Medical Journal 181:50.
<
17. Morton NS, Rain PAM(eds) 1994 Paediatric day case surgery. Oxfo^
Medical Publications, Oxford.
*
18. Frankville D.D., Spear R.M., Dyck J.B. The dose of propofi^

6.7.

||21 3

required to prevent children from moving during magnetic resonance imag

ing.// Anesthesiology. 1993. V.79. p.953-958.
19. Gemma ., Bricchi ., Ferrazza C., et al. Anestesia generale per la
risonanza magnetica. Esperienza su 100 casi.// Minerva Anestesiol. 1992. T.
58. p.415-418.
20. Janvier G. Utilisation du Diprivan en radiologie.// Ann. Fr. Anesth.
Reanim. 1994. T. 13. p. 589-592.
21. Levati A., Colombo N., Arosio E.M., et al. Propofol anaesthesia in
spontaneously breathing paediatric patients during magnetic resonance
imaging.// Acta Anaesthesiol. Scand. 1996. V. 40. p. 561-565.
22. Pickerodt V.W. Anasthesie bei neuroradiologischen untersuchungen.
Ergebnisse einenmfalebei 208 kliniken.//Anaesthesist. 1978. Bd. 27. s. 510515.
23. Manuli M.A., Davies L. Rectal methohexital for sedation of children
during imaging procedures.//Am. J. Roentgenol. 1993. V. 160. p. 577-580.
24. Lang D.M., Alpem M.B., Visintainer P.F., et al. Elevated risk of ana
phylactoid reaction from radiographic contrast media is associated with both
beta-blocker exposure and cardiovascular disorders.// Arch. Intern. Med.
1993. V. 153. p.2033-2040.
25. Jackson E., Tan S., Yarwood G., et al. Increasing the length of the
expiratory limb of the Ayres T-piece: implications for remote mechanical
ventilation in infants and young children.// Br.J.Anaesth. 1994. V. 73. p.
154-156.
26. Soret J. Association flunitrazepam-phenopheridine en neuroradiologie sans intubation.// Cah. Anesthesiol. 1984. T. 32. Suppl. p. 41-45. Spring
D.B., Bettmann M.A., Barkan H.E. Nonfatal adverse reactions to iodinated
contrast media: spontaneous reporting to the U.S. Food and Drug
Admenistration, 1978-1994.// Radiology. 1997. V. 2Q4 p. 325-332.
27. Wouters P.F., Van Aken H. Magnetic resonance imaging in children:
role of the anaesthesiologist. / / Eur. J. Anaesth. 1997. V. 14. p. 236-238.
28. Lasser E.C., Lyon S.G., Berry C.C. Reports on contrast media reac
tions: analysis of data from reports to the U.S. Food and Drug
Administration.// Radiology. 1997. V. 203. p. 605-610.
29. . ..
2001.
30. .. , .. ,
; 2; 99.
31. Morgan DE; Mikhail MD Clinikal Anesthesiology f.e.,
.. 1998.

!1 4 || 6

6.8.

,

(XV
). -'
. : , , , ,
.. 1616 ,
.
(), ^

. ^
,
.
1807, , 1812 ,
-*
.
, ,
.
-;
. ..
. 3 4.
200 .
-%
.
,
, -,
,
, ^
/
. , *
(^

,
) -*
, ^,
. ,
, #
. ( .. 2001)

? *

, , ^.
, "

6.8.

" , ,
.
,
.
:
;
(, , .);
,
.
,
, ,

, .

. -


.
,
,

. (., , .. 1999.)

: ,
, .

, -
,

.(.. , .. , ..
1999.)

. :
;
;
;

..
,

,
. ,

, ,

215

216

. ,


,

. ie
, (
, ). ( .. 1993. .. ..,
1992.; .. .. .. 1989)*.
,
,
60%
.
(). 99%,
92 96%. ,
, , ,
, 85 90%.

, 43%, , ,


(, ). (.. , .. 1999).
:

,;
, .

,
, -*
, , . ..
"
". , ^
, , ^
, , , ^
, " ,
^
.( .. 2001; . . *?

. - .
. II -^
*^/
. . 1999.)
;
)

6.8.

I 21 7

,
, .
.
.
, - ( ).
- :
- ,
.
-
,
- .

.
, ,

.
, ,
-, , . (
.., .., .., .. 1999 .
.., 1998 .)

.
( .. 1987., -. .
1998, .. . 2002, . . 1996,
.. 1995, Dogliotti .. 1931, Winnie .. . 1973)
1. ;
2. ;
3. ;
4.
() ;
5. ;
6. :



7. ;
8. .
( .., . 1998. .. 1996.
.. 1988. .. 1983. ..,
.., .., .. 1994. .. . 1983.
.., .., .., .. 1994.)
1. ;
2. .
,

21 8 I

4j

/;
, -;
, .

" ". ^;
*,
. ^
:
) ;
;
) ;
}
) , ^
. , ( , ||

,
^
, , ,
; ^
"" -
);
) ; ^
( ,
- *
). (.. 1|
.. " ^
". |
., 1999).
4

^
,

1.
,
. *

/
''v
;8'
(.. , 1997)
>

5 - 6 / , 2 /
2 - 3 /
0,02 /
1 - 2 /-/; 3 - 5 / /. ;
8 - 1 0 / / ; 8 /
.. -''
0,1 - 0,3 /; / 0,1 - 0,3 /
0,5 - 0,75 /; / 0,5 -1 /; / 0,5 - 1 /^
40 - 50 /; 30 /
/ 0,1 / ; / 1 - 2 /.

6.8.

I 219

icne , .(14 -., .

1998), (. 11).
.
,
, .
.
.
2.


.
. (7 ..
. 2- . -, 1998 ., 1- ., . 411 424,
479 - 483.)

, ,

(. 12).

( .. 1998; .. 1995; .. 1998;
. 1997; .. 1993; Amrein R , Leishman ,
Bentzinger , et al. 1987; Bailiite SH} Safferman A, Vital-Herne /,
Bernstein S 1994).

, .

, , .

().
, ,
.

,
( ., 2000). ^ : 0 ,
, .(** .. ., 2000).

220 6
12

,
(-. .. 1998)

(/)

()

++++

8,1

++++

()

++++

8,8

++++

()

++++

7,7

++++

()

++

7,8

++

()

++

7,6

++

()

++

7,8

++

.+ + + +

8,1

++++

; /;
; ;
.

/;

; ; ;

.
; /;
; ;
.
;

.
; ; ;

; ; ;

.
; ;
/; ;

<

4,5'
72

4,5'
72 ,

()

9,0

++

8,7

++

8,9

()

++++

8,2

+++

; ; ;

.
/; ;

.
/;

V*
12 "

'!$
%

,21
1
3

2 .
3 , pact*j|
. , !
- , / - ; - ;
^
-

6.8.

Ramsay.
( .. ., 1999 )

I
II
III
IV
V
VI

I 221

13

, ,
, ,
, ,
,

Ramsay (. 13).
:

1) ,
2)
,
3) ,
4) ,
5) .
, . ( .,
1995; -, .. 1998; .. . 1999).
1. : , , .
2. : , .
3. : .
4. : , , .
5. -: , .

. ( .. 1998).

,

2
.
.
, (0,5-1,5 /),
. . ,
, .
() ,
, 10
. ,
, .

222 6
1 "...................................................... ................................................................... """".................

(, )
. 1
8-20 . ,
. ,
1,0 //, ;;
,
.
(, , ). *
#,
, ^
(N--D- , NMDA). | . NMDA|

.

(, ) &
,
, ^
( ) - .
0,1 0,3 /.
?
(, ) , ^
, 0,03 0,0|
/ . !$
0,1 / $|
.
$|
, |
.
. 15
40 ( 60 )*
,

(, ).
$?
, , . $
- ; *
. / 0,04 0,07 /.
*-|
1 . #
,
**'
. 6
.

. . ^
.
^ ^

6.8.

I 223

. .
, .
, , .
1 2 0,005% -.
.
,
. .
,
.
-,
, .

.
-.

-.
, ,
,
,
.
^ ( ..
. 199; .. 1998r;BaUine SH,SafFemian A, Vital-Heme J,
Bernstein S 1994).
1. / 25-100/. 1,12+0,18 //.
1 2 /
86%.
2. / 0,054+0,015 //.
25% , ,
5, 25% .
3. / 0,02 0,3 //.
4. / 0,02 0,07/.
5. / 12/; / 3/.
( .. . 1998; 2000)
1. , ..
,
.
2.
. ,

.
3. .
4. .
:
, , , ,
.


. .
: ,
.
.
-
CVI .
. II
1,5
0,75 . (. 1).
CIII CV, -,
1,5 .
5
.

. 1,5 3 .
7
.


.
-- .
.
2
.
.
. ( ),
;
.
.

1. .

6.8.

.

.
5 8 1.
* ,
: 5 6,
7 7 1.
.
,
: , .

, ,
. .

.
.

, .

. ,
10 20%.
.

, .
,

.
. ,
30 45. .

, , , - .
. (
2,5
), ,
,
- ,
.
. 40 .
.

;

225

226 6
;
, ;

(, , );
'
;
^
*
;
*
, , *
.
**
.

. . *
&
.
*
. , *
45 ]
.
. , ,
4. . *
*
. ,
?
.
25 30.
.

;
;
;

'".

*
|
, ^

.
:
. #^
^
. , 1 2 . .
: |
.
f

.

.
=1

6.8.

227

.
.
, . 3 5
.
. .

()


.

.
.
.
L1L2L3
Th12L4 .

,
, ,
.

, ,
.
:
(L2L4),
(L2L4),
( L3),
(L4 S3).

.
.
. .
.

, 1 1,5
0,5 1 .
, ,
3 - 4
,
. ,
35 40 .
1,5 2., ,
.

228 6
. .
.
.
.
.

L4 S3 .
.,
: ,

.
.
. *
.
. 2 .

9, 22G. '14 >

'

2%

3%

1%

1,5%
2%

2%

0,25%

0,5%

0,75%
0 ,02 %

0,075
0 ,1 %

2%

3%

1%

6.8.

4 6. ,
,
. 2 4,
, .
20 . ,
,
.

. ,
.

.
.
.
,
,
( )
, 4 6
.
,
,
.
. ,
15

(Collins V 1976)

(Ti-Tn)
(-)

,
2 -1 5
1
1

0,33-0,66

,
1 -1 ,5
2 ,5 -3
4 -5
5 -6

& 16

(Collins V., 1976)

(Ti-Tn)
(Tvn-Txn)

,
2 -1 5
1
1

0,33-0,66

,
1 -1 ,5
2 ,5 -3
4 -5
5 -6

229

 . .
.
, . 1

2 4
. 20 30
.
. .

,

, "
.
,
.

;
- . ,

(. 14).
. (. 15,16; ., 3, 4,5)

. 3. .

6.8.

|| 231

.
, II ,
.
.

.
,
, .
,
, .

: 1) ; 2) ; 3)
; 4) ; 5) .


, .
, ,
, . ,
,
.
.
.
90, 50,
30 40. ,
,
5 10 .

. ,
. . 90,
,
.

'. 4.
.

. 5.
.

 " ,
,
.
,
.
. ,
3 5 , .
2
.
. *5 .
,;
.
e1
.
, ,
,
.
^
17
,

10%

4
t

75

125

200

45

60

1% -,

6 -8

8 -1 4

1 4 -2 0

90

120-150

5% - 7,5%
-

25

5 0 -7 5

75 -1 0 0

60

6 0 -9 0

0,75% -
8,25% -
;
0,5% -1,
0,75% -01

4 -6

8 -1 2

1 2 -2 0

120-150

1 2 0 -1 5 0 ';

' 1 .

(G)

17

18

19

20 .

()

1,

1,2

1,1

0,9

21

22

25

26

27

29,

... 0,8

0,7

0,4

41

U,is

rf

6.8.

,
. .
- ,
.
, 5 10% -
.
. .
.
3,8 5
22 G;
" ".
, , "".
.
,
.
( ).
45
.
1 2,
. 1 2
.
15 .
. ,
, , , , .

!V. >.

*16* IV

1 .

. 7.
.

233

34 6

(. 7).
.
.
:
:
,
,*
;
,
,
,
,
"-",
;
:
,
,
,
,
,
.
. $
( ) ,
().
j
1%
, ,
, #
,
. !
, ,
, , 4,5 6 (.
, 5, 6).

, . ?|
2-, ^
.
*
.
i

?
(22G)
. , ^
.

6.8.

I 235

1000, 1500,0

.
(, ) 0,5% -.
20. , 7-8, ,
. 3 3,5
1/ 2 .
. , ,
, , , ,
,
(. 19).
19
,

()

5% 7,5%
-
0,75% 8,25%
-
0,5% 5%
-

60 ( 1,2 )

0,75-1,5-

9 (1,2)

2 ,0 -4 ,0

12 (2,4)

2 ,0 -3 ,0

2 %
0,5% -
0,5% -

60 (3,0)
15 (3,0)
15 (3,0)

|
10 ( 10)

| 0 , 1% -

1,0 - 2,0
2 ,0 -4 ,0
3 ,0 -5 ,0

3 ,0 -5 ,0

* ,
,
.

.
.

, .
:
/ 3 5/
/ 1 2/
.
, .
(,
, ,

) "
*
.
-*
.
j
. -;
,
, .
.
.

,
.

1. .. *
, . ^
, 1998.
2. .. . ,
1995 ., .131 146.

3. . .. . ?
.
. *
. II - *
" *
". . 1999.

4. .. " ^*
. - 2001.
5. .., .., ..,
.. *
. ?
1999. 1- . . 2000 . . .32 - ,
6. .. , 2- . &
, 1998 ., 1- ., . 411 424, 479 483.
*
7. ..
.
. . ., 1997.
8. .. . .,- 1987.
9. .., .. *
, *
, . #
, 1998.
10. .., .., .., ^

6.8.

II 237

.. , 21
. VII - .
.-.. 2000.- . . .158..1
11. .., .., ..,
.. . II -. .:
. , 1999. . . .73 74.
12. .., . . ,
1998 .
13. .. (); ,
, . , . .
( ). ., 1995, . 4 5.
14. -., .. . 2-
. , 1998
15. .., ., ..
: . .: . .. , 2002. 142
16. ..
//- . , 1996.
17. ..
,
, N4/1998.
18. ...
/ /
1993. 1. . 19 22.
19. .. ..

. / / - 1992 4 5. .26
-28.
20. .. .. .. .

/ / -
1989 8 . 24 - 27
21. . .. ()
- .//. . 1996 4
*53 - 55.
22. .. ,
. .:
, 1988.
23. ..

/ / .
* ... - ., 1994.
24. .. . . ., 1983.
25. .., .., .., ..

238

fitaea

!

/ / IV *
. ., 1994. . 196 197.
;
26. . .. . !
.
- . $
. II -1
" *
". . 1999.
9
27. .. , . , . , ., , ..
"
". . . ..
. 1999.
I
28. .. , .. " !^
|
. .. 1999.
|
29. .. , .. , .. " ^
". 1
. .. 1999.
^
30. .. , .. , .. "1 *
. . 1999.
4
31. ., , .. "
: ".
. 1999.
';
32. .. -^
. //. . 1995.- 2. . 60-62.
V
33. Dogliotti .. Eine neue Methode der regionaren anaesthesie:
peridurale segmentare anaesthesie. /Zbl.Chir. 1931. Bd/&*,
H.50iS.3141-3145.
;i
34. Winnie A.P Ramamurthy S Durrani Z The inguinal paravascufef
technic of lumbar plexus anesthesia. The 3 in 1-Block// Anesth. Analg.'r
1973 - 52 - R 989-996.
>
35. Aitkenhead AR, Pepperman ML, Willats SM, et al. Compariso&$
propofol and midazolam for sedation in critically ill patients. LanC$1989;2:704-709.
.
36. Amrein R, Leishman B, Bentzinger C, et al. Flumazenil in benzo
azepine antagonism: actions and clinical use in intoxications and anesth$fr
ology. Med Toxicol 1987; 2:411-29.
^
37.
Bailine SH, Safferman A, Vital-Heme J, Bernstein S. Fluma2
reversal of benzodiazepine-induced sedation for a patient with severe ]
ECT anxiety. Convuls Ther 1994; 10:65-8.

6.9

I 239

6.9

B.JI.
,
,
,
.

, , ,
.
,
( 2-3 )
, . ,
, .
,
.
, ,
,
, ,
. ... ,...

..

,
,

[ .., 1969].

- (de Kruif):
, .

.
.
, , ,
. ,
MbI ,

^ . .
,
. . , -

!40 6
, 37% ,
, 57%
[ B.JL, .., 2002].
, -,
-
. ,
,
,
.
'
( 30 ). *
. ^
^
, ,
,
,
.
\

, -v
,
,
, . -^
, ,
.. [, 1970], ^
, , , -J
.
,
,
.

_
8 186$
,

,
1900
L. Humphrey, 0
.
, ,

, #?
, ^
<>?

6.9

I241

. , - ,
1944, ,
-
.
1945
,
,

.

.
50-
.

.
,
,
[Murray JF, 1972].
,
XX

. 1960 1975

, .
, '
, ., .., .., .., .., .., .. .
60- 70-
. .., ..,

[ , , 1965; ,
1972].
,
. .
30 ,
( ), - .

.

. , ,
,
.
*6 .

242 II 6

^
,
, .

().
.
, ;
, 9% . ^
1% (. 1). -,
.

5-"
I, II, IIIA, , IV . I 1<$;
, ^
, IV ct.
.

. ^
,

. 2 3
, *
*
. - ^
, , ^
, ( 1.),
.
*
^
15-20% ( 1.). ^'
?
,
,
.
, *
:
Q
, 15 20% ;
III - IV ., 10% ;
j
, , , ^
1|

6.9

||243

;
.
:

();
;
.

40% .
50%.

[ , ,
1997]:

, -
, - , ,
- ,
.
,

, .
,
,
(
, ..).

,
.

.1.
".

44

6

,
.

.



(, , , ,
),
, -&
, .
,
.

-
;
;
;

.

-
() ( 48 ).

;
,
(
, ),
;
( ,
);
, , .
, ;
.
() ( 2 - 3 ).
2 3
.
,

, .
.

6.9

.
.

(
).
-
,
, .

.
.
. ()
,
:
( ,
0 2, );
;
.
.
,
, .
,
,

.
(
, , ,
, , )
- .
2 3 , ,
.
,

.

( )

,
, , , ,
.
, ,

245

.
.

:
;
-;
-
;

;
;
.

-

( ).

,

,

. 20%
, .

.

*
. , ^
^
. , '
(), -'
48 72 , *
.

, .
40%
.

6.9

I 247

,
, .
,
15% 95%.
-
( 1% ).
:
, ,
, .

.
.
3-6
.
, ,
- ,
.

, , ICU .

,

,
,
2 2.5
.
. ,
, , , ,
.

,
(, , ,
, ).

.
, , , .


-;
. '
,
, V VIII * . 4

, ^
, V, VIII
.
2
nfif
, , 4
-J
, ^
, !^
.
^
.
^

*
'
|

i

""............................1

I,

~I,1.

..................

. ^
8
( ?
... 1987-2002.).

, |
40% , 16,6. *

47. ^
.
^
.
|
, |
. |
52%
ASA III-IV-V. , ,
, onp^J
. J
#
. |

6.9

, ,
.
.
, ,
.

,
. ^

.

,

. ,

25% ,
3 5 . Hef
. ,
,
,
[Reed , Kaplan JA, 1995;
MacLennan N, et al, 1998]. ,
( )
, ,
.,
.
. (<40
/)
, , ,
, .
,
,
,
.

: , , , .
,
- .
.

,
.
,
- .

. -

249

'

!50

.................................................
......

.
*
. ;
4
. *0
AD , |
, . co^jj
. -
40% -J
AD.
. -J

.
( ^
). -*
-- ..
^
, !

.

. - ;
*
, ,*
.. . -,
*;
. *
,
(. 2).
,
.

,

. , -"


, .
, ;
- , , , . ().
, *

[Ledingham IM, Watt I, 1983].
[Smith I, White , 1999]* -;

6.9

.


,


. , ,
, ,
:
;
;
;
;
.
;
;
;
() ;

,.2. .

251

252

. *
( ).
, ^
-j
, *
. ,

.
, *;
. ,

,
. . ^
|
.
, , ^

.

^
,
. 5
1 5-18
.
, |
,
. ^
37% ( ^
) . ^
^
, *?
(9,2%). , |

.
*
?
- , , *>*
. , *
, *
,
. ^
, 0*
, |
(, )
, ^

6.9 ||

. ,

.
,
,
-
.

. , ( )
,
.
,
III IV ASA
60 . ,

,
.
, 1- (. 4,
5) [
, 1999; BJI ., 2002].

, .

( 42% ). ,
- .
, ,
.

,
(. 20).


,
, .
20

1 ,
+
^

18,8%

++
37,6%

5,6%

13,6%

0,9%

2,6%

6,4%

90%<SpC>2<92%

j&Q2=0,21)

Sp02<90%

90%<Sp022%

^ 02=0 ,21)

Sp020%

0,9%

8,5%

253


, .

. , 4

,
,
.. !
, ^
, . ?!

, , ,
, |
,
, .
.
&
, ^
$
, , .
, ,
,
.

(. 3).
&
{BIS)

1 -
2 -
200 (3,8/)
500 (7,7/)
3
:
BIS ;
"* - -
4 *
400 (),
5 -

3 v*

.. 1 ^

( ).

'

6.9

I 255

(BIS) . ,
(7,7/),
(3,8/),
. ,
. ,

,
, ,
,
.
,
.
,

.
.
9,2%
.

, 5

(,
.).
()
.
()
.
,
100 /
24 .

,
( 2-3 )
. ,
()
. , 2-

.
, ,
100% .
,
- , ,
, .


, ,
. -'
:
, ,
, ,
..
,
.
1997. ...
,
. ^

,
. , , >


,
, ,
.
, ,
,

.

. .
, ^
.
;

, aCW


<
/
.
^]
, - , *|

6.9

257

, , ,
, -
.
.

:

6 ( 3 );
1
;

, ,
, ,
,
.

/ 100 200 .

100% 0 2;
2,5-3 / (
80 250 ) ;
100% 0 2
, .

, , , .

0 2 2-
ASA IV 60
2
.

17 .
\

>58 6

............................................................

........

TT
X' , \-1

+
: ( 15 )

80

2 - 2,5 /

5 - 6 /

200 -

50

450 -
25

25 - 50^

--
: , ; ,
.

80 ,

2 - 2,5 /

200 50

50

5 - 6 /

450 25

50 100

1 -1 ,5 /

100

25

3-

+
: .

80

2 - 2,5 /

200
50

50 - 100

1,25 -1 ,5 /

100

( 3 - 4 )
10 - 20 _

20

6.9

259

+
:
ASA III-IV;
; 60 .
:
- 400 ;
- 0,5%-1,0 20,0 (250 1,0);
- 5% - 400,0 (0,9% NaCl) 2,0
(500 );
- 20 100 (10,0) 20,0
( 5 1; 1,25 1 ).

80

2 - 2,5 /

200
,
50

5 0 - 100

1,25 -1,5 /

100

( 3 - 4 )
1 0 - 20

20

<65
0,5

+
:
ASA III-IV;
*; 60 .

80

5-8 //
, <160; <120

2 - 2,5 /

200
50

5 0 -1 0 0

1,25 -1 ,5 /

100
20

( 3 - 4 )
10-20

>60 II 6

1. .., .. : , ,' j
. , 1997, 6, 51-55.
2. .. . -, 1966.
3. B.JL, ..
-
. III (. .), .
. 2002; 2: 18-19.
4. ., ..
- ^
. (. 3- ). . ^
. 2002; 2: 18-19.
5. B.JI., .., ..

III-IV ASA . . 2002, 3: 44-48.
6. .., . , 1965.
7. .., .., ..
*
: VII
, , 1999:115-117.
8. .. . , 1970.
9. Ledingham IM, Watt I. Influence of sedation on mortality in critical
ly ill multiple trauma patients. Lancet 1983; 1: 1270.
10. MacLennan N, Heimbach DM; Cullen BF. Anesthesia for major
thermal injury. Anesthesiology 1998; 89: 749-770.
11. Murray JF. The history of analgesia in bums. Postgrad Med J 1972;
48: 124-127.
12. Reed AP, Kaplan JA. ( , )
(. .). , 1995
13. Smith I, White P. Total Intravenous anaesthesia. BMJ Books,
London 1999.

..
Day case anesthesia ( , DCA)

, -
(Outpatient anesthesia),
,
(day
case surgery, one day surgery, ODS).

,
.
, ,
,
,
. , 70- XX
,
.

100 . . Ries (1889 .)
, ,
. J.H. Nicoll
(1909 .) 9888

,
10 ,
[. ,
*998; L.R. Pasternak, 19?8; J.G. Whitman, 1994].


, ,

 ,
7- 14- .

XX ,

.
(1961 .).

R. Lawrie (1964 ., ). W. A. Reed ;
J.C. Ford 1974

,
5700 -^
[http://www.amb-surg-centr.narod.ru/; S.K. Pandit, 1999;
L.R. Pasternak, 1998].


. 1980 . ,
,
,
.
- .
, ,'
,
, 1977 . 774 . , **-
1986 . 50 . .

,
, ,
,
.
, , *
,
. ,
,
, **
, . 95% Ml
, . ^ ;
2 ^
,
, ^;
(. . 21) [http://www.amb-sui^f
centr.narod.ru/; P.J. Conaghan et al., 2002; F. Mazdisnian et al.; L.RfS
Pasternak, 1998; J.P. Sales, 2001].
\ ||
, #

21

,
.
.
.

.

.
.
.
.
.
.

.
, -
.
,
.

.
.

,
.

1970 ., 1990 . 25 %
,
, , 75%. ,

. ,
,
,
.

:
1. (
, ).
2. ( ,
,
).
3. ( ,
,
).
4. ( ,

, ).
,
,
,
, , ,
^ [., 1997;

263

264 7
.. , .,1999; P.J. Conaghan et al., 2002; J.P. Sales, 2001].



,
(. 22) [P.J. Conaghan et al., 2002; L. Jouffroy, 2001; M.
Markovic, 2002; L.R. Pasternak, 1998; J.P. Sales, 2001].
22
,

, ,
, -,
, , , .

,
,
, ,
.

, ,
,
.

, ,
, , , ,
, , ,
,
, .

, , ,
.

,
, ,
- .

, , ,
,
( ),
.

, .

( ), .

, , , ,
, - .

' , ,


. ,
,
.

- 1963 ., 4
465 ,
, . 1987 .,

,
. ,

,

,

[.. , 2000b; .., 1997;
http://www.amb-surg-centr.narod.ru/].
,
,
,
.
^
, ,

.

-
, 3500
,


[http://www.amb-surg-centr.narod.ru/].
,
( ):
1. .
2. .
3. .
4. .
5. .
, , (
):
1.

265

I-------------------------------------------------------------------------------------------^
.
2. ^,
.
}
3. -,
.
4.
.

5. $
.
^
(
, ^
-;
. , ^
||
, Day case;
anesthesia (DSA).

, ko m V
, *
:

(ODS-),
[. , 1998; . , .,1999; . Madl<a|
K.Danner, H.Kawach, 1996; L.R. Pasternak, 1998; J.Stichei
G.Hempelmann, 1997):
|
1. ( ), ?
).
f
2 . ,
, *
,
. 9
, ctf&f
.
, . <^
*
, , |
?
(. ).
3. , <
( , ). :

, , ,
, ,
.
, ,
, .
4. (Recovery room
/RR/) .
(Postanesthesia
unit /PACU/).

.
;
,
.
RR PACU Second-stage recovery unit
(SSRU) .
5. , , :
- ,
- ,
- ,
- ,
- .
-
:

.
,
.
(RR),

, .
-
,

. ,

,
( )
, [.. , 2000b;
^, 1997].
-
[. , 1998; . , 2000b; .. , 1997; . Madler, K.Dattner, H.Kawach, 1996; L.R. Pasternak, 1998;
J-Sticher, G.Hempelmann, 1997].
(

267

 , .
(
EtC02).
" .
( //, Sp02, ,
, EtC02).
.
- ( ).
(, ,
Diprifusor TCI)w
.

.
.

.
- .
- .
.
, .
, .

.
1; 5; 10; 20 , *^
.
( )
.
( ).
(, ). ;
, .
- .
, ^
, .
,
.
;
, ^
, **
.

^^^ ^^^^^^


, ,
.
,

,
.

, , [.
Madler, K.Danner, H.Kawach, 1996; L.R. Pasternak, 1998; J.G. Whitman,
1994].
,

.

,
[..
, 2000; , 1998; .. , 1997; R.G. Ouellette,
1999; A. Prabhu, F. Chung, 2001]:
1) ;
2) ;
3) ;
4) - ;
5) ;
6) .
,
.
. ,
ODS-
.
.
, (),
,
, (
)
. ,
,
,

,
.
. '
,
.
, ,
(
)
.

. , ,

269

270

.......... |lHl,f....................................................

..........

...............

.
-*

. , ASA^
,
, *'
. h

^
-7
ASA I ASA II.
, ,
ASA III ASA IV [ , 19$|
R.G. Ouellette, 1999; A. Prabhu, F. Chung, 2001]. ,

- . ^
[.. , 1997; .. , ., 1999; *
Madler, . Danner, . Kawach, 1996; J. Sticher, G. Hempelmann, 1997;
G. Whitman, 1994], (. 7.4.).
*

#*1
.
, , ,
, . ?
. 23.
,
(
). #
, $|
, , npaicn3|
. , npo^f*
.

.
*:
(HEALTHOUIZV #
Cfl|
(HEALTHQUIZ),
Apfelbaum J.L. et al. [. , 1998] 1988 .
|
(, , , >*1
).
. 1^ |!
,
. . '
# }||
HEALTHQUIZ

23

[.. , ., 1999; L.R. Pasternak, 1998; J. G. Whitman, 1994].
.
, , .
.
( , ).
.
.
.
.
.
.

, .

- 4 ?
- ?
?
- , ?
- ,
?
?
- ?
?
?
?
?

?
?
?
?
?
?
, ?
- ?
?
-, ?
- ?
?
|^ ?
?
:

, ?

?
^^ .

271

272 II 7 ,
,
, -,
. ,
(
, ),

. HEALTHQUIZ
,

. HEALr
THQUIZ ,
^
,
.

( ) ODS-
48 24 1 20
, -*
.
, ,

.
,
, ,
, ,
, .
,
,
^
[. . *
., 1999; . Madler, K.Danner, H.Kawach, 1996; L.R. Pasternak,
1998; A. Prabhu, F. Chung* 2001].

,
,
,
[.. , 1997; . Madler, .Danner,
H.Kawach, 1996; L.R. Pasternak, 1998; J.G, Whitman, 1994].

ODS-
:
*
;

,

.
,

[. , 1998; A. Prabhu, F. Chung, 2001],
:
;
;

;

, ,
;

-
DS-,
, :
1. ( ,
).
30%
50%, 100 /.

,
,
.
2.
.
3. .

.
,
( ) .
4. , (

; ,
).
5. 40 ,
- (
, ,
).

:
, , , ,
, , ;

273

174

,
;
, ACT,
;
()
.
,
,
ODS-
:
, ,
2 3 ;
, 2 3 ;

1 2 ;
6 .
*
- ()
.

,
g
. ,
( )

.

( *,
) ,
^
, , ?
.
, , - . ,
.
(*
> ,
, ,
ODS-. **,
, (
, ,#>
..). , ,
4-6 .
, . *?
,
. $
. -

 ||

275

, .

, [.., . ,
1999; R.G. Ouellette, 1999; A. Prabhu, F. Chung, 2001; J. Sticher, G.
Hempelmann, 1997; J.G. Whitman, 1994].
[.
, 2000; .. , 1998; .., 1997]

,
,
.

, ,
, 3 330
12 1997 . , ,
.

.
ODS-
,
- - (.
) [.. ., 2001] , , -

:
__ ____ ___ ____ 20___ .

____________________________________________
_________________ _____________________
( )

( )

( )
( , , )

,
()
() , -
- .


. * : - -

, ,
- ,
, .
______________________________________

(). ,
, .
, ,
,
. (, , , .).
, |$
.

, ,
.
: , ,
, , , , , ,
, , .

, , , .
.

,
.
()
, , ,
, , ,
, ,
..
, ,

: , ,
, ,
,
. ,
, , ,
, , .
, .
,
.

_________________ ___________________ _

, .
,
, ,
, .

,
. ,
,
.
, , , ,
, , ,
,

.

,
.
,
_______________
. , ,
,
:_________


. ,

, , 24
, ,
12 , ,
4- ,

.
,
. ,
()
, , , ,
, , ,
, ,
, , , (),
. ,
, , .
, , ,
-

,
, , -

277

178 7

Hi

_______________________________________________ __
, () ,
. ,
. , #
.
, ()
(, ):


;

,
.
,
, ,
. ,
, ,
, ,

. qxeMe
, .
,
.

.
_________________t
_______________ ;____________ ___________ :_________

, ,
(
). , ( ) ,
.

||279

,

:

:
:
;

.
,
ODS-
:
,
( ASA) ,
.
.
:
,
;

, ,

;


,
.
,
60 .
, ODS-
( 7.2.),
,
,
30-90 ( 120) ,
[..,
1997; L. Jouffroy, 2001; . Markovic et al., 2002; L.R. Pasternak, 1998; A.
Prabhu, F. Chung, 2001].
( ASA) .
I II ASA, ..
,
; ,
,

>80 11 7
(, ).

ASA III ASA IV
,
[. , 1998; .. , 1998; L.R. Pasternak, 1998;
A. Prabhu, F. Chung, 2001]. 80- XX
,
,
,
ASA III
, ASA I
ASA II. 1987 *,
87000
,

. ,
1500000
, . . DEramo (1999), 144
24
, . . Newland et al. (2002),
[P.P. Higgins et al., 2002; M.J. .Hunter, A.M.
Molinaro, 1997; P.J. Nkansah et al., 1997].
,
.
,
, ,
,
(
),
,
,
[.., 1997; F. Chung, G.Mezei, 1999; P.P. Higgins et
al., 2002; L.R. Pasternak, 1998; A. Prabhu, F. Chung, 2001].


:
.
ASA III ASA IV,
(, )
.
.

.
. -
,
, ,

||281

.
.
. III
IV
.
.
. -
-
, ,
,
.
.
,

. .
, ,
,
. ,
ODS-
.
I II
ASA.
,
,
, . *
,
, 44 ( 60)
,
, , .

. ,
, 1
.

,

,
,
.
, ,

. , ,
,
,
[. , 1998; .,
., 1999; S.K. Pandit, 1999; P.F. White, 1998 ; J.G. Whitman, 1994].

282

-1
. . ^
,
, . ,
, , ,
.
, ,
.

24 . -'
-*
.


.
, , ^
,
. . , *;;
, , ,
,
[. , 1998; ..*
1997; .., ., 1999; L.R. Pasternak, 1998; A. Prabhu, Chung, 2001}.
>

, , &

, ,;
.
,
;
,
, .
(

*

,
. ,
, , ^
,
[. , 1998; ..,
., 1999; F. Chung, G.Mezei, 1999; L.R. Pasternak, 1998; H .CJf
Whitmire, 1999].
^

(ASA 1 ), , -*;

. 2,5-3

.
.
,
. ,
,
, ,
[.., 1997; J.G.
Whitman, 1994].


.

.
, ,
2 .
1
. ,
,
(5-7,5 per os).

(10-30 )
(
)
ODS- 3
[., ., 1999; F. Chung, G.Mezei, 1999; L.R.
Pasternak, 1998; J.G. Whitman, 1994; H.C.Jr Whitmire, 1999].
()

. . J. Cote et I. . Cohen (2002)

0,25 / 97 %
, 86 % ,
.
(1-2 )
,
. ,


[.. ., 1999; .. Alcaino, 2000; F. Chung, G.Mezei, 1999; J.J.
^agelhout, M.J. Boytim, 2001].
. ,
,

283

284 II 7
,
-,

.
,
. EMLA ( )
.

, ,
.
,

, ,

,
(), (, ) 2- ()

, [ Chung;
G.Mezei, 1999: . Coloma et al., 2002; . Grimsehl et al., 2002; L.R,
Pasternak, 1998].

,
,
, ,
, ..

.

,
. , , *

.

[., 1997; .., ., 1999; L.R*
Pasternak, 1998].

,
. ,
, 4
, , *
, *

.
: 6 ;
4 ; 3 .

.
3 , ,
,
. S.K. Pandit
. (2000), J. . Crenshaw . . Winslow (2002)
,


,
2-3 , ( ) 6
, 8
[J.T. Crenshaw, .. Winslow, 2002; S.K. Pandit et al.,
2000; P.F. White, 1998a].

,
, .

, , ,
, .

, ,
,

.
,
,
[. , 1998; .. , 1998; .., 1997;
.., ., 1999; J.G. Whitman, 1994]
( III), ( IV),
( VI).
,
,
.

, .
,

285

286

: ?
, , , , .
*
., noi
, ,
,
.
,
, *
, (,
) <^
. ,
, , ,
,
ODS- ^
, . ?
. $

,
.
,
*
, ^
[A.JI. /
.. , 1998; .., ., 1999; J.J. Nagelhout,
Boytim, 2001; J.G. Whitman, 1994].
1^

- ,*
, *
.
,
[.
, .. , 1998; S. Badrinath et al., 2000; A. Gloor et al., 2001}.
#

(0,15-0,25
/).
(, , ;

(0,05-0,1 / /). *$
2-3 *
, [.. , 2002; *9*
, 1998; .. Alcaino, 2000; J.J. Nagelhout, M.J. Boytim, 2001] -
80*
. #*

287

:
L .
2.

() .

.
,
,
()
.
,

(TCI)
[.. ., 2002; . , ..
, 1998; S. Lopez-Alvarez et al., 2001; J.J. Nagelhout, M.J.
Boytim, 2001].

, ,

. dec, ,
.

( / = 0,42),
.
,
,
, .

, ,
, [..
, 1998; . Coloma et al., 2001; N.A. Mahmoud et al., 2001; L.R.
Pasternak, 1998].


, . ,
,
( = 2,05 .%). ,
^
(
),
2 /. , , -

288 II 7

....... ......... ......

.... 8
..........
1 1
.

[.. , 1998; A. Dolk et al., 2002;
J.J. Nagelhout, M.J. Boytim, 2001; J.G. Whitman, 1994].

?
()
,
() , (, ) () .
*
^
. ^
,
.
.

.

, ,
.
*

.
, ,
,

. ,
, *
30%, , , *
. ,
1/3
. *

[.. ., 2001; .. , .
,1998; A. Dolk et al., 2002; J.J. Nagelhout, M.J. Boytim, 2001].
,

^
, , **
, # ?
.
, *
, , *

. ,

(,
, )
. ,

(JIMA),
, ,
,

, .

,
, , . ,

J1MA ,
(3,3% 17,5%
) [P.P. Higgins et al., 2002; A. Junger et al., 2002; D.W. Todd, 2002].
,
.
. (, )
,
, ,
,
[. , 1998; ., ., 1999; J.G. Whitman,.
1994].
,
,
, . , . Mikat-Stevens
. (2001) d-,

[. Mikat-Stevens et al., 2000].
) .
* , , , .

^ , > , ] ( 2 2,5 ),

289

 , . , -

, 0,5 1
.
; ,
(
1 ) ,
( 30 70 ?
) -
[.. , 1998; .., .***
1999; J.G. Whitman, 1994].

,v:;
,v

, - ,
,
. , ;
;
, --^

jjji
,
*1
. - ^
, *
( -'
).
.,
[. , 1998; P.F. White, 1998; P.F. White, M.F, Watcha, 2001].
, ;
(-,
).
: ,
, -;
,
;
*
, ;
;

*
(Pencil Point) 27G, *
,
, #
, .

||291

,

.

1-2 , -
[C.R. Quivers et aL, 2001; S.B. Kang et al., 1994; F. Lopez-Soriano et al.,
2002; A Y Stewart et al., 2001].


, (1,5
9,6%) [.., ., 1999; S.B. Kangetal., 1992]. ,
,
. ,

,
.

,

.


.

,
, .

- -
,
,
.
.

( ) 0,5% [A. Casati
et al., 2002; V.W. Chan et al., 2001; S.M. Klein et al., 2002; J.B. Mayfield et
al., 2001; M. Moritebugnoli et al., 2001].

.
, ,
, ,
3
//. -

, , ,
, .
,

2-5 //. ,
, 6-
18 /.
,
, (9 /),

12 / [.., 1997; .. , .,
1999; J.G. Whitman, 1994]. , J. . Leske
Bennett . ^
20 /
2-4 / *
, ,,
,
[J. Bennett et al., 1999; J.B. Leske, 1996].

, ?
. , ?
. ^
,
, ,

.

,
. -

[. ;
1998; .. ., 1999; P.F. White, M.F. Watcha, 2001].

, ASA 1969 ,
:
, '
.
, ,
. ,

(Recovery Room). *

PACU (Postanesthesia care unit
).
PACU
,
,
ICU (
)
[. , 1998; .. Philip et al., 1990; P.F. White, M.F. Watcha,
2001; J.G. Whitman, 1994]. [.
, .. , 1997; .. ., 2000; .. ,
.. ,1985; .. ., 1999; P.F. White, 1998],

, :
( ,
);
(, ,
);
(,
);
( );
(
, /
,
,
.
,
ODS-

, , ,
.
,
,
[. , 1998; P.G. Duncan et al.,
2001; RF. White, M.F. Watcha, 2001; J.G. Whitman, 1994].
.
, ,
.
.
.

.
.

5 .

293

94

, Sp02 =
94% 5 10 .

, SSRU
(Second-stage recovery unit)

, , ODS-. ,
,

. , , ^

, [. , 1998; .. ., 1999; P.F. White, M.F. Watcha, 2001].
,
PACU, ,
, , .
(Preemptive Analgesia) *,

.
-"
, SSRU, 4
,
[. , 1998; R.I. Patel et al., 2001].
'

, -^

, ,
ODS- **
.
,
, ,
() )|
(), ^;
[. , 1998; .. , 1998; ., .
1999; P.F. White, M.F. Watcha, 2001]. 5
#
, , .
, *
*,
# [.. ., 2000; .. , J lJ v

295

985; .. ., 1999].
,
, ,
,
, .
( ,
..),
( , ,
), (-
, .),
( ,
), ,


. ,
:

,
,

,
,
.




(). ,
,

(, );
(spectral edge frequency
SEF-95) (median frequency MF, SEF-50),
50% .

(BIS) ,

[.. , 1998;
.. ., 1999; . . ., 2001; L.A. Conlay,
2002]. BIS 20
32,6%,
19 , [.. , 1998; .. ., 1999; . Anez et a l, 2001; D.J. Pavlin
et al., 2001]. , BIS

296 7
[ Nelskyla et al., 2001].
, . ..
,
(),


[.. , 1998;
.. ., 2002; . . ., 2001].


, '
, :
( ^
() );
(,
);
(, , , ..).

[.. , 2002; ..
, 2002; .. Philip et al., 1990; P.F. White, 1998a; J.G. Whitman,
1994]:
, , 40 , ;
() 0,2 15 ,
, , 1
5 3 1 .


/
,
. , :
,

, cnocot>etf
.
, &
,

() 3 3,5 /, (10 1^
/), (5 7 /), (20 25 /)
, (6 8 /) [. , ..
1997; .. , .. ,1985].

- (,
/, /),
() (, .),

[.. , 2000; .. ,
2002; .. Pendeville et al., 2001; . Viitanen, P. Annila, 2001].


[. , 1998; S.B. Kang et al., 1994; F. LopezSoriano et al., 2002; P.F. White, M.F. Watcha, 2001].

.
,
, .

. ,
, ,
.
,
. ,
1 1,5 ( 75 )
.
( 6-8 ) ,
.
, ,
( ) [. , 1998;
., 1997].
; ,
, ,
.
, 30
- 3 6 ,

- .

.
;
(, ,
),
.

. ,

297

2 9 8 7
............................

..............

""

......

.......................

---------------

-* 4 i

, ,
(
10-20 /) [. , 1998; ., ., 1999; . White
M.F. Watcha, 2001].
,
" , N
, -\
, . ,
ODS- ,
, , , -,
, .
,
, ilq&j1
, ;
. ,

.
, -_
,

. '

.
,
, ,
. ,
,
,
[A.JI. , ..
, 1998; J.J. Nagelhout, M.J. Boytim, 2001; R.G. Ouellette, 1999; ^;
Prabhu, F. Chung, 2001; P.F. White, M.F. Watcha, 2001].
%;
ocHQ-v
, , ?
( Fast tracking concepts) nep*J
, PACU IJ
Apfelbaum et al., 2002; P.G. Duncan et al., 2001; P.F. White, 1998].

^

.

,
,
. ,
, ,

70%.

. ,

(0,05 0,15 /() 2 (!)
.

. ,
, ,
( 4 8 )
,
[..
., 2001; .. ., 1999; . Coloma et al., 2001;
S. Lopez-Alvarez et al., 2001;*P.E. Pendeville et al., 2001].
,
,
. , 1996
( )
. ,
, .
(ORG9487) 10 ,
"
60 ,
. ORG7617 ORG9616
*
,
[J.J.
Nagelhout, M.J. Boytim, 2001; L.R. Pasternak, 1998; P.F. White, 1998a].

{ ) [.. , 2000; .. 2002; . , 1998; . . , 2001; . Coloma et al., 2001;
Viitanen, P. Annila, 2001]:
1* ,

299

300 I

'

,
, - ,
,
, , ,

; -.
. ,
-
-
.
2. ^
(Preemptive Analgesia) i r
,
.

(), ^
: , , , . ,

, ^
. ,

.
,

.
3. *

. ^
-2- (, ),

. , -2-
. -2-, ,
, , -.
.

-, , .


-
. , 5 /()
-

[: Coloma et al., 2001]. () 0,075 / (

. )
,
, ,
, [. . , 2001]. ,
, ,
,
.

.
,

,
,

.
, ,

. 2.830.000
( 1973 1995 . ) ,

( 1,4 1.000.000 )
,
[Nkansah P.J.,
1997]. , ,

(1
142 ), ( 2,3%) [.. DEramo, 1999; M.J. Hunter,
.. Molinaro, 1997].

Office-anesthesia ( , )

[R.F. Kaplan., C.I. Yang,
2002; .. Ross, J.B. Eck, 2002; P.F. White, M.F. Watcha, 2001]. -
,
.
,
,
ODS-. office-
,

301

I
.
office-,
,
, (
),
.
, ,
, *,

. , -
:
. 7
. $$
-]

ODS- -^
. .
. (
) , ;
, . ^
ODS-, ,
, *>
..
, , ^
,
. , F. Mazdisnian . (2002), ^
^
,
, , 2 30 $
, &?.
ODS- ( ) [F. Mazdisnia$
et al., 2002]. ,
- ,
. ,
,

. ,
' , ,
.
,
, ,
( ), *^
.

,
, o f fic e -

303

, - (
ASA,
: ,
, , ).
-
, ,
, ,
, ,
,
..
( )
office-,
,
[R.F. Kaplan., C.I. Yang, 2002; F. Mazdisnian et al., 2002; AD. RLabajo, 1998; AK. Ross, J.B. Eck, 2002; H.C.Jr Whitmire, 1999].

1. . .
./ . .. .
-, 1998. -.98 - 102.
2. ., .., .., ..,
.. () - .- . 2001. -2. -.4 8.
3. .., ..
. -
. -1997.-1.
4. ..
. - www.msanesth.com\daycasesurgery\01.htm. -2000
5. . , ,
.
.- www.rusanesth.com\daycasesurgery\05.htm. -2000
6. .., .., ..

rusanesth.com\daycasesurgery\05.htm. - 2001
7. .., ., ..
: .,- .:, 2000.- 440 .
8. ..
.- VIII
. . .- , 2002.- .32
9. .. -

304 I

-1
,- . .... ...- , 2002.- 25 .
10. .., .., .., ..,4
. . TCI - . - VIII . .
.- , 2002.- .26
11. . .
/ ...- -, 1998.- .89 - 92.
12. .., ..
.- .:,1998.- 240 .
13. .., .., .., ..;
: , , . - |
.- 1999.- Nq6.- . 19 - 23
14. . .
. -
- 1 2001- . 43 - 45
15. : . ./ . .. , .
: 1,- .:, 1985.-376 .
16. .., .., .., .,*
..
.- .- 1999.-(<
3.-. 12-15 .
17. / . .. ,
.-.: , 1998.-288.
18. ./ . ...-.:- v
, 1997.-656 .
19. . 2:. ./ . .^
, ..- .:, 1999.- 552 .
20. .., .., ..
: . - .- 1999.-"
6.-'. 23-28
21. . ., . ., . ., .
. npvt
. -
.- 2001.- 3.- . 16-17
22. . -
- . - http://www.amb-suigcentr.narod.ru/
23. Alcaino .. Conscious sedation in paediatric dentistry: current philoso
phies and techniques. Annals of the Royal Australasian College of Dental Surgeons.
15:206-10, 2000 Oct.
24. Anez C., Plapaceit J., Sala J.M., Fuentes A., Rull M. The e ffe c t of
encephalogram bispectral index monitoring during total intravenous an esth esia
with propofol in outpatient surgery.- Revista Espanola de A n e s t e s io lo g ia
Reanimacion.- 48(6):264 - 9, 2001 Jun-Jul.
<
25. Apfelbaum J.L., Walawander C.A., Grasela .., Wise P., McLeskey C*
Roizen M.F., Wetchler B.V., Korttila Eliminating intensive postoperative care

same-day surgery patients using short-acting anesthetics.- Anesthesiology. 97(1): 66

74, 2002 Jul.
26. Badrinath S., Avramov ., Shadrick ., Witt T.R., Ivankovich A.D. The
Use of a Ketamine-Propofol Combination During Monitored Anesthesia
Care.[Miscellaneous] -Anesthesia & Analgesia. - 9(4): 858 - 862, April 2000.
27. Bennett J., McDonald, ., Lieblich S., Piecuch J. Perioperative rehydration
in ambulatory anesthesia for dentoalveolar surgery.[Miscellaneous].- Oral Surgery,
Oral Medicine, Oral Pathology, Oral Radiology, & Endodontics. - 88(3): 279 284, September 1999.
28. Casati A., Cappelleri G., Berti ., Fanelli G., Di Benedetto C., Torn G.
Randomized comparison of remifentanil-propofol with a sciatic-femoral nerve
block for out-patient knee arthroscopy.- European Journal of Anaesthesiology.19(2): 109 - 14, 2002 Feb.
29. Chan V.W., Peng P.W., Kaszas Z., Middleton WJ., Muni R., Anastakis
D.G., Graham B.A. A comparative study of general anesthesia, intravenous region
al anesthesia, and axillary block for outpatient hand surgery: clinical outcome and
cost analysis. - Anesthesia & Analgesia.- 93(5): 1181-4, 2001 Nov.
30. Chilvers C.R., Goodwin A, Vaghadia H., Mitchell G.W. Selective spinal
anesthesia for outpatient laparoscopy. V: pharmacoeconomic comparison vs gener
al anesthesia. -Canadian Journal of Anaesthesia.- 48(3):279 - 83, 2001 Mar.
31. Chung F., Mezei G. Adverse outcomes in ambulatory anesthesia. [Review].
-Canadian Journal of Anaesthesia. - 46(5 Pt2):R 18 - 34, 1999 May.
32. Coloma ., Chiu Jen W., White P.F., Armbruster S.C. The Use of Esmolol
as an Alternative to Remifentanil During Desflurane Anesthesia for Fast-Track
Outpatient Gynecologic Laparoscopic Surgery.[Miscellaneous Article] Anesthesia & Analgesia. - 92(2):352 - 357, February 2001.
33. Coloma ., White P.F., Markowitz S.D., Whitten C.W, Macaluso A.R.,
Berrisford S.B., Thornton K.C. Dexamethasone in Combination with Dolasetron
for Prophylaxis in the Ambulatory Setting: Effect on Outcome after Laparoscopic
Cholecystectomy. - Anesthesiology.- 96(6): 1346 - 1350, June 2002.
34. Conaghan P.J., Figueira E., Griffin M.A., Ingham Clark C.L. Randomized
clinical trial of the effectiveness of emergency day surgery against standard inpatient
treatment.- British Journal of Surgery. - 89(4): 423 - 7, 2002 Apr.
35. Conlay L.A The Effect of Bispectral Index Monitoring on End-Tidal Gas
Concentration
and
Recovery
Duration
After
Outpatient
Anesthesia. [Miscellaneous] - Survey of Anesthesiology.-46(4): 185- 186, August
2002
36. Cote C.J., Cohen I.T, Suresh S., Rabb ., Rose J.B., Weldon B.C., Davis
j-J., Bikhazi G.B., Karl H.W., Hummer K.A., Hannallah RS., Khoo K.C., Collins
f- A comparison of three doses of a commercially prepared oral midazolam syrup
ln children. - Anesthesia & Analgesia. - 94(1):37 - 43, 2002 Jan.
37. Crenshaw J.T., Winslow E.H. - Preoperative Fasting: Old Habits Die Hard:
Research and published guidelines no longer support the routine use ofNPO after
ttudnight, but the practice persists. - American Journal of Nursing. 102(5): 36 44>May 2002.
. 38. D'Eramo E.M. Mortality and morbidity with outpatient anesthesia: the
assachusetts experience.- Journal of Oral & Maxillofacial Surgery. - 57(5): 531
i " 6,1999 May.

305

39. Dolk A., Cannerfelt R., Anderson P.E., Jakobsson J. Inhalation anaesthesia
is cost-effective for ambulatory surgery: a clinical comparison with propofol during
elective knee arthroscopy.- European Journal of Anaesthesiology.- 19(2): 88 - 92,
2002 Feb,
40. Duncan P.G., Shandro J., Bachand R, Ainsworth L. A pilot study of recov
ery room bypass (fast-track protocol) in a community hospital. - Canadian
Journal of Anaesthesia. - 48(7):630 - 6, 2001 Jul - Aug.
41. Gloor A., Dillier C., Gerber A. Ketamine for short ambulatory procedures
in children: an audit.- Paediatric Anaesthesia. - 11(5): 533-9, 2001.
42. Grimsehl K , Whiteside J.B., Mackenzie N. Comparison of cyclizine and
ondansetron for the prevention of postoperative nausea and vomiting in laparo
scopic day-case gynaecological surgery.- Anaesthesia.- 57(l):61-5, 2002 Jan.
43. Higgins P.P., Chung F., Mezei G. Postoperative sore throat after ambulato-J
ry surgery.- British Journal of Anaesthesia.- 88(4):582-4, 2002 Apr.
4 '*
44. Hunter M.J., Molinaro A.M. Morbidity and mortality with outpatient anes- thesia: the experience of a residency training program. Journal of Oral &
Maxillofacial Surgery. - 55(7):684-7, 1997 Jul.
45. Jouffroy L. Ambulatory surgery: safety, quality. - Bulletin de lAcademie ^
Nationale de Medecine. - 185(6): 1045-55, 2001.
J
46. Junger A, Klasen J., Hartmann B., Benson ., Rohrig R., Kuhn D.,
Hempelmann G. Shorter discharge time after regional or intravenous anaesthesia1?
in combination with laryngeal mask airway compared with balanced anaesthesia1
with endotracheal intubation.- European Journal of Anaesthesiology. - 19(2): 11924, 2002 Feb.
- ;
47. Kang S.B., Goodnough D.E., Lee Y.K., OlsonRA, Borshoff J.A, Furlano,
M.M., Krueger L.S. Comparison of 26- and 27-G needles for spinal anesthesia fo
ambulatory surgery patients. - Anesthesiology. - 76(5):734-8,1992 May.
^
48. Kang S.B., Rudrud L., Nelson W., Baier D. Postanesthesia nursing care fof(
ambulatory surgery patients post-spinal anesthesia.-Journal of Post Anesthesia
Nursing.- 9(2): 101-6, 1994 Apr.
j
49. Kaplan R.F., Yang C.I. Sedation and analgesia in pediatric patients for pr6*&
cedures outside the operating room.- Anesthesiology Clinics of North America. *J
20(1): 18J.-94, vii, 2002 Mar.
50. Klein S.M., Pietrobon R , Nielsen K.C., Warner D.S., Greengrass RA*
Steele S.M. Peripheral nerve blockade with long-acting local anesthetics: a survey"
of the Society for Ambulatory Anesthesia. - Anesthesia & Analgesia. 94(l):71-6,
2002 Jan
v
51. Leske J.B. A Prospective Randomized Double-Blinded Study of the Effect
of Intravenous Fluid Therapy on Adverse Outcomes on Outpatient Surgery AORN Journal-1996, Vol. 64(5).-pp 822-823

52. Lopez-Alvarez S., Bonome G.C., Aymerich C.H., Alvarez R.F., Rodrigue^
R.A, Cobian L.J.M. The effect of propofol vs desflurane on recovery from anes- j
thesia with remifentanil in outpatient surgery. Revista Espanola de Anestesiologia
Reanimacion.- 48(8):370-4, 2001 Oct.
"
53. Lopez-Soriano F., Lajarin B., Rivas F., Verdu J.M., Lopez-Robles JHyperbaric subarachnoid ropivacaine in ambulatory surgery: comparative study^
with hyperbaric bupivacaine. - Revista Espanola de Anestesiologia !
Reanimacion.- 49(2):71-5, 2002 Feb,

307

54. Madler ., Danner ., Kawach . Specialist graduate education in accor

dance with the recommendations of DGAI and OGARI. Preoperative anesthesiologic patient visit, outpatient anesthesia. Risk assessment, patient preparation and
planing perioperative procedures. - Anasthesiologie, Intensivmedizin,
Notfallmedizin, Schmerztherapie.- 31(10):633-53, 1996 Dec.
55. Mahmoud N.A, Rose D.J., Laurence A.S. Desflurane or sevoflurane for
gynaecological day-case anaesthesia with spontaneous respiration? Anaesthesia.
56(2): 171-4, 2001 Feb.
56. Markovic ., Bandyopadhyay ., Vu ., Manderson L. Gynaecological
day surgery and quality of care. - Australian Health Review.- 25(3):52-9, 2002.
57. Mayfield J.B., Carter C., Wang C., Warner J.J. 'Arthroscopic shoulder
reconstruction: fast-track recovery and outpatient treatment.
Clinical
Orthopaedics & Related Research. - (390): 10-6, 2001 Sep.
58. Mazdisnian F., Palmieri A, Hakakha B., Hakakha ., Cambridge C.,
Lauria B. Office microlaparoscopy for female sterilization under local anesthesia. A
cost and clinical analysis. - Journal of Reproductive Medicine.- 47(2):97-100,
2002 Feb.
59. Mikat-Stevens ., Sukhani R., Pappas A.L., Fluder E., Kleinman B.,
Stevens RA. Is succinylcholine after pretreatment with d-tubocurarine and lidocaine contraindicated for outpatient anesthesia? Anesthesia & Analgesia. 91(2):312-6, 2000 Aug.
60. Montebugnoli ., Calo P., Rodler ., Rolli ., Broccoli E., van Oven H.,
Pignotti E. Orthopaedic one day surgery: anaesthesiologic techniques used and
intra- and postoperative complications. Minerva Anestesiologica.- 67(9 Suppl
1):223-6,2001 Sep.
61. Nagelhout J.J., Boytim M.J. Pharmacologic rationale for anesthetic agents
in ambulatory practice. - Journal of Perianesthesia Nursing. - 16(6):371-8, 2001
Dec.
62. Nelskyla K.A., Yli-Hankala A.M., Puro P.H., Korttila K.T. Sevoflurane
titration using bispectral index decreases postoperative vomiting in phase II recov
ery after ambulatory surgery.- Anesthesia & Analgesia.- 93(5): 1165-9, 2001 Nov;
63. Newland M.C., Ellis S.J., Lydiatt C.A., Peters K., Tinker J.H., Romberger
D.J., Ullrich F.A, Anderson J.R Anesthestic-related Cardiac Arrest and Its
Mortality: A Report Covering 72,959 Anesthetics over 10 Years from a US Teaching
Hospital. - Anesthesiology.- 97(1): 108-115, July 2002.
64. Nkansah P.J., Haas D.A., Saso M.A. Mortality incidence in outpatient
anesthesia for dentistry in Ontario. - Oral Surgery Oral Medicine Oral Pathology
Oral Radiology & Endodontics. - 83(6):646-51, 1997 Jun.
65. Ouellette RG. Controversial issues in outpatient anesthesia: adult and pedi
atric. - CRNA - the Clinical Forum for Nurse Anesthetists. 10(l):2-5,1999 Feb.
66. Pandit S.K. Ambulatory- anesthesia and surgery in America: a historical
background and recent innovations. - Journal of Perianesthesia Nursing.
!4(5):270-4,1999 Oct
67. Pandit S.K., Loberg K.W., Pandit U.A Toast and tea before elective sur
gery? A national survey on current practice. - Anesthesia & Analgesia.90(6):1348-51, 2000 Jun.
68. Pasternak L.R. Outpatient anesthesia. In: Longnecker DE, Tinker JH,
Morgan GE Jr, et al, eds. Principles and practice of anesthesiology. 2nd ed. St.

$08 II 7
Louis: Mosby, 1998.-476 p.
69. Patel R.I., Verghese S.T., Hannallah R.S., Aregawi A., Patel K.M. Fasttracking children after ambulatory surgery. Anesthesia & Analgesia. - 92(4):91822, 2001 Apr.
70. PavlinD.J., Hong J.Y., Freund P.R., KoerschgenM.E., Bower J.O., Bowdle
T.A. The effect of bispectral index monitoring on end-tidal gas concentration and
recovery duration afler outpatient anesthesia.- Anesthesia & Analgesia.
93(3):613-9, 2001 Sep.
71. Pendeville PE., Kabongo F., Veyckemans F. Use of remifentanil in combi
nation with desflurane or propofol for ambulatory oral surgery.- Acta
Anaesthesiologica Belgica. -52(2): 181-6, 2001.
72. Philip B.K., Simpson .., Hauch M.A., Mallampati S.R Flumazenil
reverses sedation after midazolam-induced general anesthesia in ambulatory sujr*#
geiy patients. - Anesthesia & Analgesia. - 71(4):371-6,1990 Oct.
73. Prabhu A., Chung F. Anaesthetic strategies towards developments in day
care surgery.- European Journal ofAnaesthesiology - Supplement. 23:36-42,2001.
74. R-Labajo A.D. Office-based surgery and anesthesia.- Current Opinion in
Anaesthesiology. - 11(6):612-621, November 1998.
75. Ross A K., Eck J.B. Office-based anesthesia for children. - Anesthesiology
Clinics of North America. - 20(1): 195-210, 2002 Mar.
*
76. Sales J.P. Role of ambulatory surgery in France international compar
isons. - Bulletin de lAcademie Nationale de Medecine. - 185(6): 1037-44, 2001.
77. Stewart AV., Vaghadi H., Collins L., Mitchell G.W. Small-dose selective
spinal anaesthesia for short-duration outpatient gynaecological laparoscopy: recov
ery characteristics compared with propofol anaesthesia. - British Journal of
Anaesthesia. - 86(4):570-2, 2001 Apr.
78. Sticher J., Hempelmann G. Anesthesiological management in outpatient
operations. Patient selection, premedication visits, anesthesia procedure, postoper
ative phase and discharge, the outpatient anesthesia workplace. Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie. 32(11):687-98, 1997 Nov.
79. Todd D.W. A comparison of endotracheal intubation and use of the laryn
geal mask airway for ambulatory oral surgery patients. - Journal of Oral &
Maxillofacial Surgery. - 60(l):2-4; discussion 4-5, 2002 Jan.
80. Viitanen H., Annila P. Analgesic efficacy of tramadol 2 mg kg(-l) for pae
diatric day-case adenoidectomy. - British Journal of Anaesthesia.- 86(4): 572-5,
2001 Apr.
81. White P.F. Ambulatory anesthesia - fast tracking concepts. - Anesthesia &
Analgesia. - Suppl: 153-6,1998 Mar.
82. White P.F. Ambulatory anesthesia in the 21st century. - Current Opinion in
Anaesthesiology. ll(6):593-594, November 1998.
83. White P.F., Watcha M.F. Pharmacoeconomics in anaesthesia: what are the
issues?.- European Journal of Anaesthesiology - Supplement. 23:10-5, 2001.
84. Whitman J.G. Day-Case Anaesthesia and Sedation. - Oxford, 1994.298 pp.
85. Whitmire H.C.Jr. Medicolegal considerations for office-based anesthesia in
dentistry. - Dental Clinics of North America.-43(2):361-72, vii, 373-7,1999 Apr.

 8
"

............

. ., ..,

. ,
, -
, .
,
, ,
.

. , (
, ),
, , .
(
.., 1998).
, ,
,
.
.
, , ,
,
.
.
,
( .., 1996).
, ,
,
,
, , , ,
- .
, , .
:
, , ,
.

1 II 8
, ,

,
( .. ,, 2001). '
,


.

, , ,

*
( .., 1996).
?
, ,


... , ,

. ( .. ., 1996).
.

,
:
, , ;
;
, ,
: Q
,
, ;
,
, ,
, ;
;
(. Maze, 1998).

,
( )?
:
1.
. *
,
,
,
.
, , ,
. ^
, *
, . ( .., 1999)?

 || 3 1 1

2. .
,
, , . ( .. ., 1998);
3. .
, , ;
4. .

,
. ,
,
.
, :

.
,
(
) (
). ( .. ., 1996)
, ,
,
.

,
, ,

. ( .. 1998)

:
1. .
2. .
3. .
4. .
5. .
6. .
7. .
8. (-, ). ( .., 2002)
9. .

:
(, , ),
;
( );
();
(, ). ( , 1998).


, ,
, .
: , ,
, .
,
, ,
. ^
, .. &**
:
24 48 ., ,
72 . .
,
( .., 2000). ,
.

.
, 2 4 .
3 5
10 .


.
.
.

- ,
,
(
.. ., 2001).
0,01-0,1 // ( ., 1998). , ,'
,


6 . ,
.
.
200 ,
100
100-200 /. ( ., 1998)
/

, ,
:

-
, ;

;
,

,
.
.
, ,
.
. 0,03 0,05
/ 2 - 4 . . ( ., 1998).

: , ,
. ,
, , ,
.


. ( .., 2000)

,

- ,
. : ,
.

. , * .
20 , 2-4 . ( .., 1996)

313

31 4 || 8

: ,
(
), ,
( ~
, ,
), , , .

.
( 30 40 .,
15 20 ). , . . ,

.. **
.
,
. 0,5 //,
0,5
/ 5. .
0,5 3 //. (
.. ., 2002).

- :


;


.

,
, .
,
,
.
, &
, *
^
(. Maze, 1998).

, ,

. ( .., 1996).

,
.
,
.

,
.
( ,

). ( .. ., 1997).

,
, .

,
,

.
, ,

,
.

-
.

Karen A. Thompson D. Goodale,

(2,6-) 1973 .
.
1973

315

!16

II 8
2,6-.
, 350
,
(, ,
, ,
, ). (.. Thompson et al., 2002)
\ 6761:1 pH 6-8,5,
. , 2% 2,6-, Cremofor EL .
, *
- . &
^ ^
1% .
,
Cremofor, ,
,
, Cremofor.

,
,
. (. Hart, 2000)
.
^
1983 , *
1986 . 1986 .
1989 *

.

, ,


, . (.. Thompson et al., 2000)
1993 .
(
30 40 . , ).
,
, . ,
(
).

. ( .., 1998)

( ).

,
,
, .
( )
(, ).



0,3 4,0 //
.

1,5 4,5 //
.

,
,
,
,
, . , 1989
,
,
.
,
,

.
, Zeneca
Pharmaceuticals ( AstraZeneca),

(),
. (Data on file AstraZeneca, Wilmington, 2002.)
, (, , ),
. , ,
,
pH.
Zeneca Pharmaceuticals , ,
().

317

NaOOCCH2 _

. CH2COONa
NCH2CH2N
2

2
+

NaOOCCH2

CH2COONa

, ,
.
:
*
:
-^ 25 55 %, **!
120 125 %;
.
^

%
70 % ||
1 /../. 3 5 ;
^
70 %, 2
/.. 6 ;
55 %.
,v
^
, ,
. ^
. ^|
'4

,
.

:
3 . , 5-0 0,9% 3 4 8 10 . (.Hart, 2000.)
:

;


;

;
;
;
.
,
: , in vitro
, 0,005%
24
.
.
(Data on files AstraZeneca, Wilmington, 2000*)
20
, 7 , 10 ,
3- (. 24).
Zeneca Pharmaceuticals



, .
24

Staphylococcus
Aniens
1 6538
2 29737
3 NCIB9968
4 NCTC 10442
Staphylococcus epidermis
knteiococcus faecialis
Bacillus subtilis

Pseudomonas aeruginosa
Escherichia coli
Klebsiella pneumoniae
Burkholderia cepacia
Enterobacter agglomerans
Acinetobacter calcoaceticus
Serratia marcescens
Flalimonas oryzihabitans
Moraxella osloensis
-Battsiaidisiiasilis........ ............

Candida albicans
Candida parapscilosis
Aspergillus niger

319


,
,
. - '
, ,
(T.L.Higgins et al., 2000).
,
- , - .
, .
,

.'
N.Barr , , -1
, ,
,
.
, . . <
,
( 20%), 48

, (J.Barr et al., 2000).
D.Goodale, R.Hannalah, I.Cohen

, ,

.
69
1 17 (36
) (33 ).
.
, . *
,
. ^


( 0.05),
.
. , ,
(J.Barr et al., 2000).
,
.
,
, ,
,
. -

 ||

().
Zaloga G.R, Youngs . Teres D. ,

, 50
.

15 29 .
1-2 /,
65
. 10 ,
60- ,
60
(25, 50, 100
200 //).
. , , , Sp02,
, ,
, .

,
.
.
, 1
;

.

.

(G.P.Zaloga, E.Young et al., 2000).
(/)
25

50

100

20

15

10
5

//
1

. 3. , ?

200

321

------ -----

-----------------------

------------- '

60 120 (. 3).
Wahr J. Vender J., Horrow JC. et al. ;
,

- .
102 34
85 ,
().

.

, , ^
, ,
. -,
- '
( 0,980,07 / (N=51), - 0,9900
/).
.

.
(J. Wahr et al., 2000).
E.Abraham, R.Tharratt et al. ,
5 *
,
,

.
85 18 8 ,
,

48 . 43 1-
, 42 2- .
#
(2 3 Ramsay),
(4 5 ). ' 5 //
. 63 %
( APACHE II il9). -
-*
. 98% 1- 95% 2-<
,
.
, , .
70%
(25 ),
.

,
.
1-
2- .
2-
( 1,0 /)
.
1 5-
. 2- .

4- ,
. ,
.


BE, 02 02 (.Abraham et al., 2000).
, ,

, ,

,
4
.
,
.
.
Schnider TW, Minto CF, Andresen . et al.
.
24
( 25,
50,100 200 //).
.
,
.

.
, .
20002001 75 ,
, , . ..
,
,
0,005% ,

.

323

24 8

122 . 63
, 59
.
, , , 28
(1,7%) ,
. ,
, 11 (17%).
(=0,004), '>
, DESIRE (Diprivan EDTA
Survival in Intensive Care), , - ;
-^
,
.

28
. , DESIRE
SOFA (sequentional organ failure assesment
) ,
28
( ,
)
(D.L.Herretal.,2000).
DESIRE, Jurgen Schuttler
Friedrich Alexander (-, )
,
, ,

.
O.Zaloga, D.Teres ,

( )
.

.
,
(G.P.Zaloga et ai., 2000).

,
.


. 5
60
,
.

 ||

1. .. .
., ,_2000.
2.
.., . 1999.
3. ., .. .
, 2001.
4. .. .
, 1998.
5. ..

.
., 9, 1996.
6. / . ..
.-.: , 1998,
. 149-157.
7. .. .
. , N3/2000.
8. .., .
.
, 1998.
9. ..

.
., 1996.
10. .. :
, , 1999 ., . 42-43.
11. ..
, . 1998.
12. . -., . .
: 1-/ . .-.-.:
- , 1998, . 174-185.
13. .., .., ..
:
. , N4/2001.
14. ..
. ., 1998.
15. ., . - .-.:
- ,2002.
16. ., ..
.
, ,
3,19/
17. .. - -

325

126 8

----------------------------.------------------------------------_

----- -^

. ., , 1996.
18. . - '
, ., , 1997.
19. ..
. , 2, 1996.
20. B.Hart Diprivan: A Change in Formulation (correspondence) Eur
J Anaesthiol 17, 2000: 71-73.
21. D.L.Herr, K.Kelly, J.B.Hall, J.UIatowski Safety and Efficacy of
Propofol With EDTA When Used for Sedation of Surgical Intensive Care
Unit Patients Intensive Care Medicine 26, 2000: S452-462.
22. Data on file AstraZeneca, Wilmington, Delaware, 2.
*
23. E.Abraham, P.J.Papadacos, R.S.Tharratt Effects of Propofol
Containing EDTA on Mineral Metabolism in Medical ICU Patients Wit&A
Pulmonary Dysfunctions Intensive Care Medicine 26, 2000: S422-432.
24. F.Sata, S.Araki, K.Murata, H.Aono Behavior of Heavy Metals in
Human Urine and Blood Following Calcium Disodium Ethylendiamine
Tetraacetate Injection: Observations in Metal Workers J Toxicol Environ
Health 54,1998: 167-178.
25. G.P.Zaloga, D.Teres The Safety and Efficacy of Propofol
Containing EDTA. A Randomised Clinical Trial Programme Focusing on
Cation and Trace Metal Homeostasis in Criticaly III Patients Intensive
Care Medicine 26, 2000: S398-399.
26. G.P.Zaloga, E.Youngs D.Teres Propofol-Containing Sedative
Increase Levels of Parathyroid Hormone Intensive Care Medicine 26,
2000: S405-412.
27. J.Barr, G.P.Zaloga, M.T.Haupt, M.Weinmann Cation Metabolism
During Propofol Sedation With and Without EDTA in Patients With
Impaired Renal Function Intensive Care Medicine 26, 2000: S433-442.
28. J.Wahr, J.Vender Effects of Propofol With and Without EE)TA on
Haemodynamics and Calcium and Magnesium Homeostasis During and
After Cardiac Suigery Intensive Care Medicine 26, 2000: S443-451.
29. K.A.Thompson, D.B.Goodale The Recent Development of
Propofol (DIPRIVAN) Intensive Care Medicine 26, 2000: S40U-404.
30. M.Maze. Sedation in the intensive care unit. International
Congress and Simpozium, series 221, 1998.
31. T.L.Higgins, M. Murray, D.H.Kett Trace Element Homeostasis
During Continuous Sedation With Propofol Containing EDTA Versus
Other Sedatives in Criticaly III Patients Intensive Care Medicine 26,
2000: S413-421.

 9


. .

,
.

. .
,
.


, .
. ,
, . , ,
, (.. - v
) .
,
.. . , ,
,
, , .
, - .
:
(),
()
();
()
.

:

. - , .

()

128

1 " |

.................

.......................

| .. i . i

( =
0.7). = 8 10 Hg.

2 Hg. ,

()
30% . , - . (
, ,
.
. -*

( ).
:
( - )
(/* 5) = ---------------- 79.99

1500 1700 (/*5).

( ..)
.
().
.
.
, 95 100%;
30%.

(), (Sa02)
(02) ,
. , .
, , , ,
,
(02)
.

, , ,
:
, ,
, ().
: ,
.
( : .) MV02,
- (),
(), [/
(; ) (,

||329

, )] .

() .
,
() , ,
, MV02
.

Sp02 Sv02.
,
,
, -
.
,
:

(, -);
(CaOJ
() ;
-
, , ,
;
- ()
- (),
, ;
, , ();
, , ,
( ) ,
(

, ,
)
);
,
, , ;
,

.
.
, ,
.

. , ,
,
, .

 '
.

, *

. ;'
, .
. , ,
-,
. , nq^i
, 30%
.
. - ,
, ,
.
.
S- , 1
, . S-
.
, .. - .
:
;

^ ;

.
.
.
.
0.5'
/(*); ?
, , -'
;

.
- (5-10 ), (0.5 1.0 );
.

( ), : (12- 30 /); ^
.
.

||331

, ,
.
60 /.

, ' , , .
, ,
.
.
.
: ,
(-
111 .), (). .
.
, -
; ,
.
-
.
.
.
,
, (0.4 0.8 /).

, ,
.
,
100 /. 160 /.
. , , , , , (, ,
, ), (), ,
, ,
.
,
, :
;
;
;
(,
-).

- , ..
.

332 II 9
.
- (-V) 1 ,

0.2
. . ,______________________________

iTrrltu

rij

.'.

'

\r

&

:
:|] i ! \ J i

;!rfc

i { <Jn r ; s;t
i f :1|. tj* PJ f I 1 4^^ ii .

itrr 1[pi f i f nni\

- I
i
p

If

. 1. .

- V II . :

1 *4
a- . -R
,
.
w

r?

-i

P i

<

J puuv

lip

ij,

d 2S

...tipHb. *?

s fiP f

& .

-tHi
|

WFi\

. 2. .

2 a-
. 3,4 ..
. -R .
.

. 3. .

-V III .
. - 1
a- . -!;
, . *
(<45 /).
,]

.
-V 1., , ,

||333

- V I I cm.

1 ,
,
.

().
2 ;
-V III cm.,

. .
()
,
QRS .

,

.
, R .
QRS, ,
,
, . ,
.

. 6. .

. QRS .
,
. ,
,
.
:
;
;
;
/ ( 0.25 );

334 9

' $

(, , );
( ).

350 - 600 1 .

. 7. .

-, .
, -^
, , , ^
.
.
(, 0.5 /), (, &
0.5 /), (, 5 10 /),
.

250-350 1
. 2:1 1:1
150 1 .
, "

1?
-

<< 1>:

.sUSt) M u jli

'

,r

&

. 8. .

: (
), , ^ , .

-
. !

. 9. .

^
QRS, ,
.

.
,

335

,
, ,
. , ,
, R (..
R ).
,
.
, .

(1 / /
1 2 /).
,
150 250
/. .

. 10. .

.
.

* ;V

V 7*.

I I

7V

ill til.

cvJ

*<- ^

:2:

. 11. .

--.

. ,
(
) .
-R .
. .
.

33611 9

= ^ =

^ =

. ,

, =

....

== ^

, 6
/ .
,
.
^

^^^^
-1-
.

-
-
.
. ,

(OJ1C).
:
^

;
;
a-v
;
,
(, ,
);
;
-.
/ (0.4 ; 0.15 /*
).
-.
: , , .

- -
, .
:
;
;
;
;
;
.

||337

(20 100
; 0.5 1 ; 0 .5-4/
)
- -.
- .
.
, ,
.
-

(). ,
-
.
, , ,
,
.
. . ,
- .
() (1-30 / )
. - , - ;

-2-.
, , ,
.
.
(1-20 /(*) ,
, - . < 4 /*
,
.
-
, , , . 10 12 /*
-1-
, .

.
, .
,,
. ,
(2 30 /*) ,
-1-, -2- >.-1- .

338 II 9

-1 -1- . /
, ..
-2- -1- .
.

, , , . :

. ^
OJIC, * g
.
(
, ),
.
(5 -10 )
.
.
- -
.
, , , . .

-,
,
.
-
.
(0.7.5/ , 5 - 1 0 /*) ,
.
5 , 10
12 . ,
, , ,
.
. 20
.

(, ) (0.5 1.0 )
-1- -2-

,
. 3 4 .
-

- .
-1-
,
,
() -1-.
10 20 ; 0.25
0.5 /; 50 200 /(*).
.
5 .
9 . , ..
;
,
. ,
,
.

Na
.

. ,
N 0, .
. .



. , , , ,
, , ,
OJIC.
,
.
,
,
. , ,
,
, , ..
, -

331

.
,
.
, ..
(1-2 ) (2
). 0.1 /(*)
.
-
, - -4
. In vivo

. , -^
, ,
. 4 ,
,
.
,
.
.
,
.
10
/, 1/
2.5 .
, , , , ,
.
.
, () 100% Na. ,
50 , 150 /, , /
15 .

, , ,
, , , , , .


.
.

.
, ,
, - .

= ,
-

1341

(), , ,

.

, , ..
,
. -.

,
.
. ,

.

.

.

0.1 /*. , - 50^-100 .

.
.

.

.
,
/
,
( --), 5-10
/ .

.

.

.

.
.

4 2 9

. / ,
per os .

.
, .

.

, --. 6 / . ,
(12 ). (<1)
.

, . 1
,
( ) ()
.
.
(, ,
) . (
).
,
(), : , , .
,
, ( 33 . ),
, ,
(, -
),
(, ..).
( ).
,
, ,
.
,
.

( ),
(, , ).

PEEP
: , -

 ||

, , .
.
- , ,
;
,
,
;
,
, ;

;
;

;



;
:
(, ); - (); ,
(); (); ;
().
.

;
,

,
;
30% - ;

. _
,
,
;
;
;
, PEEP ..;
;
( )
,
.

343

144 11 9

.
:
,
(, , , . ), , ,
, .
;
;

(, ..);
%?
, ,
;
.
,
, :
;
;
, , () 0.5 1 /;
, ,
/ 20
/
;
Na 20 /
;
1 /
;
,

.
,
, , (
).
-

, ( ).
.

.

||345

,
-, -, .
0 2
, ,
- .
(, , )
.
02
(
), ,
( ),
- .
.

:

;
:
-
/ ;
;
(
,
)
:
;
, , ,
- ;
()
, ..
0 2 :
;
;
- .
0 2
:
;

;
..
.
,

346

, , .
:
;
, ;
;
(, ; ;
. .
J
. .
, , , .
:
;
P-pulmonale, ,
;
;
.
:
;
;
- ( 5 4 );
( ..)
- ;
, .

,
.
:
;
;
;
, (
..).

.
, ,
, .^
.
.
.
.
.

,
, .
:
( 60% ),
;
( 20%),
;

( 5%);
( 15%,
: ,
).

.
,
:

;
-
.
, ..:
,
, ;
-
;
,
;
,
, , , ,

;

,
, , ;
100-300%,

347

348

|| 9

400-500%,
0 2;

.
.
(
21 .);

;
( , *
..);
, , , <
;
.
,

,
, 2 , .
.
, ,
, ,
,
.
. 42
, .
:
;
,
, ,
;
,
, , , , ;

() , ;
.
.

, ,
.
: .

.

349

, -

, .
. , - *

.

.
' :
;
;
;
;
,
(, ,
,
);
;
;
;
0 2

.
.
1. ,
.
.
2. 2.5 / / 10 /
. ,
.
20 ,
50 .
3. , , ,
, ..

(IgE) ^,

: , , ..

350 || 9

, IgE
.
:
;
;
, ir
, ; )
.
:
;
100% ;
;
;
;
.

1. .. . - .: , 1994;
-656 .
1
2. . . / /
.
. - -, 1997. - .91-95.
^ ;
3. .., . . - .: *
, 1989. - 303 .
4. .. . - Mi
, 1998. - 288 .
5. - .., .. : 1. - . . - . - .: - - , 1998.
431.
)
6. - .., .. : 2*.
. - . . - . - .: - - , 2000. ^
366 ;
"
7. . . / /
. $
. - -, 1997. - .76-82.
8. . 0
. / / ^
. . - *
-, 1995. - .36-43.
9. Barash P.G., Cullen B.F., Stoelting R.K. Clinical Anesthesia. - Philadelphia
Lippincott, 1989.
;<;
10. Davidson J. K., Eckhardt WE III, Perese D.A. Clinical A n a e s t h e s ia
Procedures of the Massachsetts General Hospital 4-th Edition. - 1993. - 707
11. Gravenstein N. Manual of Compliqations During Anesthesia. Philadelphia^
Lippincott, 1991.

12. Holdcroft A. Body Temperature Control in Anaesthesia, Surgery and

Intensive Care. - London: bailliere Tindall, 1980/
13. Jones D.E., Ryan J.F. Treatment of the Acute Hyperthermic Crisis,
Malignant Hyperthermia. // In: Malignant Hyperthermia. Britt B.A. (ed.) Boston: Martinus Nijhoff, 1987. P397.
14. Kallos ., Lampe K.E, Orkin EK. Pulmonary Aspiration of Gastric
Contents. / / In:Complications in Anesthesiology. Orkin F.K., Cooperman L.H.
(ed.) - Philadelphia: Lippincott, 1983. - P152.
15. Levy J.H. allergic reaction during anesthesia. / / J. Clin. Anesth. 1(1):
44, 1988.
16. Orkin F., Cooperman L. Complications in Anesthesiology. Philadelphia:
Lippincott, 1983. - P. 152.
17. RainesD., Chang B.S.-P, Patafio O. Intraanesthetic Problems. / / In: Clini
cal Anaesthesia Procedures of the Massachsetts General Hospital, 4-th Edition,
edited by Davidson J. K., Eckhardt W.E III, Perese D.A. - 1993. - P247-272.

B.JI.

. ,

. .. ,
..


. .. .
.. . ,

. .. ,
..
. , ,
,
.. ,
. .
. ,

. .. .

..
... ,
..
. ,

. .. ,
..

. .. ,
..
. ,

. .. ,
..

. ..
.

351

..

125363, . , ., . 6, . 7, . 702.
/.: (095) 497-57-60,497-67-55,
E-mail: info@miklosh.ru, www.miklosh.ru

02780 07.09.2000 .
20.09.2004 . 60 90 1/16.
. . 1. . 22 . 5000 .
404-

ISBN 5 - 9 0 0 5 1 8 -3 5 -3
5 18 3 5 9

..